<?xml version="1.0"?>
<Ontology xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="https://w3id.org/SKGO/phm"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     ontologyIRI="https://w3id.org/SKGO/phm">
    <Prefix name="" IRI="https://w3id.org/SKGO/phm#"/>
    <Prefix name="dc" IRI="http://purl.org/dc/elements/1.1/"/>
    <Prefix name="ns" IRI="http://www.w3.org/2003/06/sw-vocab-status/ns#"/>
    <Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/>
    <Prefix name="phm" IRI="https://w3id.org/SKGO/phm##"/>
    <Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/>
    <Prefix name="wot" IRI="http://xmlns.com/wot/0.1/"/>
    <Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/>
    <Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/>
    <Prefix name="bibo" IRI="http://purl.org/ontology/bibo/"/>
    <Prefix name="foaf" IRI="http://xmlns.com/foaf/0.1/"/>
    <Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/>
    <Prefix name="skos" IRI="http://www.w3.org/2004/02/skos/core#"/>
    <Prefix name="vann" IRI="http://purl.org/vocab/vann/"/>
    <Prefix name="terms" IRI="http://purl.org/dc/terms/"/>
    <Prefix name="terms1" IRI="http://ns.nature.com/terms/"/>
    <Import>http://ns.nature.com/terms/</Import>
    <Import>http://purl.org/ontology/bibo/</Import>
    <Import>http://xmlns.com/foaf/0.1/</Import>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="dc:creator"/>
        <Literal>Zeynep Say, Aysegul Say, Sahar Vahdati, Said Fathalla</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="terms:license"/>
        <Literal>Creative Commons Attribution 3.0 (CC BY 3.0)</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="owl:versionInfo"/>
        <Literal>2.0</Literal>
    </Annotation>
    <Annotation>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <Literal>PharmSci is an Ontology for describing Pharmaceutical Science research.
The aim of building ontology is to help Pharmaceutical Science researchers to find scientific research close to their work or their research topic. Ontology covers the study design for the pharmaceutical science research which is a Clinical Study includes experimental and non-experimental studies.</Literal>
    </Annotation>
    <Declaration>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
    </Declaration>
    <Declaration>
        <Class IRI="http://purl.org/dc/dcmitype/Collection"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:AgentClass"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:BibliographicResource"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:Frequency"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:LicenseDocument"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:LinguisticSystem"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:MethodOfAccrual"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:MethodOfInstruction"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:PhysicalResource"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:Policy"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:ProvenanceStatement"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:RightsStatement"/>
    </Declaration>
    <Declaration>
        <Class abbreviatedIRI="terms:Standard"/>
    </Declaration>
    <Declaration>
        <Class IRI="http://www.w3.org/2000/10/swap/pim/contact#Person"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Assay"/>
    </Declaration>
    <Declaration>
        <Class IRI="#AssayKit"/>
    </Declaration>
    <Declaration>
        <Class IRI="#AssayMethod"/>
    </Declaration>
    <Declaration>
        <Class IRI="#BlotAnalysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Calculations"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Cell"/>
    </Declaration>
    <Declaration>
        <Class IRI="#CellLine"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Chemical"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ClinicalProblem"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ClinicalStudy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ClinicalTrial"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Disease"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Drug"/>
    </Declaration>
    <Declaration>
        <Class IRI="#EasternBlotting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ExperimentKit"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ExperimentMaterial"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ExperimentSetting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ExperimentalStudy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Gene"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Hypothesis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Investigation"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </Declaration>
    <Declaration>
        <Class IRI="#NorthernBlotting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ObservationalStudy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Patient"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Probe"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Reagent"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ReviewStudy"/>
    </Declaration>
    <Declaration>
        <Class IRI="#SouthernBlotting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Specimen"/>
    </Declaration>
    <Declaration>
        <Class IRI="#StatisticalAnalysis"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Study"/>
    </Declaration>
    <Declaration>
        <Class IRI="#StudyDesign"/>
    </Declaration>
    <Declaration>
        <Class IRI="#Treatment"/>
    </Declaration>
    <Declaration>
        <Class IRI="#WesternBlotting"/>
    </Declaration>
    <Declaration>
        <Class IRI="#ex_vivo"/>
    </Declaration>
    <Declaration>
        <Class IRI="#in_silico"/>
    </Declaration>
    <Declaration>
        <Class IRI="#in_vitro"/>
    </Declaration>
    <Declaration>
        <Class IRI="#in_vivo"/>
    </Declaration>
    <Declaration>
        <Class IRI="#levels_of_mdr1_mRNA"/>
    </Declaration>
    <Declaration>
        <ObjectProperty abbreviatedIRI="terms:alternative"/>
    </Declaration>
    <Declaration>
        <ObjectProperty abbreviatedIRI="terms:coverage"/>
    </Declaration>
    <Declaration>
        <ObjectProperty abbreviatedIRI="terms:creator"/>
    </Declaration>
    <Declaration>
        <ObjectProperty abbreviatedIRI="terms:type"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#addressesStudy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#examinedBy"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasClinicalProblem"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasDisease"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasExperiment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasExperimentKit"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasExperimentMethod"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasHypothesis"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasInvestigation"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasProtein"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasStudyDesign"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#hasTreatment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#has_Treatment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#investigate"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#investigatesProblem"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#isClinicalTrial"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#obtainedfrom"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#obtainedfromPatient"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#performsExperiment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#refersExperiment"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#resistantTo"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#testOn"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useAssay"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useCellLine"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useDrug"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useGene"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useProbe"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useReagent"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useSpecimen"/>
    </Declaration>
    <Declaration>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
    </Declaration>
    <Declaration>
        <DataProperty abbreviatedIRI="terms:abstract"/>
    </Declaration>
    <Declaration>
        <DataProperty abbreviatedIRI="terms:alternative"/>
    </Declaration>
    <Declaration>
        <DataProperty abbreviatedIRI="terms:bibliographicCitation"/>
    </Declaration>
    <Declaration>
        <DataProperty abbreviatedIRI="terms:identifier"/>
    </Declaration>
    <Declaration>
        <DataProperty abbreviatedIRI="terms:title"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#assayTitle"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#failureReason"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasAssayMethod"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasDrugEffects"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasEligibilityCriteria"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasEvidence"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasExperimentalResult"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasFindings"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasLimitations"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasMutationResult"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasOverexpressionGene"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasProblemSolution"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasSuggestion"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasTargetingMethod"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasTissueLocalization"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#hasTitle"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#name"/>
    </Declaration>
    <Declaration>
        <DataProperty IRI="#treatmentOutcome"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="http://purl.org/dc/aboutdcmi#DCMI"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Agent"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:AgentClass"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:BibliographicResource"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Box"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:DCMIType"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:DDC"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:FileFormat"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Frequency"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:IMT"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:ISO3166"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:ISO639-2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:ISO639-3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Jurisdiction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:LCC"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:LCSH"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:LicenseDocument"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:LinguisticSystem"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Location"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:LocationPeriodOrJurisdiction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:MESH"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:MediaType"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:MediaTypeOrExtent"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:MethodOfAccrual"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:MethodOfInstruction"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:NLM"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Period"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:PeriodOfTime"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:PhysicalMedium"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:PhysicalResource"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Point"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Policy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:ProvenanceStatement"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:RFC1766"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:RFC3066"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:RFC4646"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:RFC5646"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:RightsStatement"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:SizeOrDuration"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:Standard"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:TGN"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:UDC"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:URI"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:W3CDTF"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:abstract"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:accessRights"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:accrualMethod"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:accrualPeriodicity"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:accrualPolicy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:alternative"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:audience"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:available"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:bibliographicCitation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:conformsTo"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:contributor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:coverage"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:created"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:creator"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:date"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:dateAccepted"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:dateCopyrighted"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:dateSubmitted"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:description"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:educationLevel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:extent"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:format"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:hasFormat"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:hasPart"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:hasVersion"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:identifier"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:instructionalMethod"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isFormatOf"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isPartOf"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isReferencedBy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isReplacedBy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isRequiredBy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:isVersionOf"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:issued"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:language"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:license"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:mediator"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:medium"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:modified"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:provenance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:publisher"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:references"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:relation"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:replaces"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:requires"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:rights"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:rightsHolder"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:source"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:spatial"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:subject"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:tableOfContents"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:temporal"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:title"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:type"/>
    </Declaration>
    <Declaration>
        <NamedIndividual abbreviatedIRI="terms:valid"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#A._T._FoJo"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ABCA2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ABC_genes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ADE"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ALL"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AML"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AML_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ARUN_K._RISHI"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Accumulation_Bioassay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Actinomycin_D"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Acute_lymphoblastic_leukemia"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Adrenocortical_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Advanced_and_recurrent_breast_cancer_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#American_Type_Culture_Collection"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Anthracyclines-doxorubucin_daunorubicin_epirubicin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Anthranilic-acid-based_drug"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayKit9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#AssayMethod"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Asuka_Mizutani"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BBR3390"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BCRP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BD_Biosciences_La_Jolla_CA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BH3_profiling"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BH3_profiling_method"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Bevacizumab"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Blast_populations_in_the_two_bioassays"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Bone_marrow_aspirates"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Bortezomib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Branimir_I._Sikic"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Breast_cancer_samples"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CAVE"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CCL_127__PC12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CI1033"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CLONTECH"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CML"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Caitriona_Holohan"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cancer_Cell_International"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cancer_drug_resistance_an_evolving_paradigm"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Carboplatin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Catherine_Booth-Genthe"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cetuximab"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Chemotherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cheol-Hee_Choi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ClinicalProblemSolution9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Clonogenic_survival_assays"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Colchicine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Colerectal_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Colon_Tumor"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Colon_carcinoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Crizotinib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cyclosporine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Cytarabine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#D._G._POPLACK"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#D._J._SLAMON"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#DOUGLAS_D._ROSS"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Daniel_B._Longley"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Dasatinib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Daunomycin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Daunorubicin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Delta_RNA_Fingerprinting_kit"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Describe_various_approaches_to_combating_multidrug-resistant_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#DiOC2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Doxorubicin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Drosophila_white_gene"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Drug_Resistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Drug_resistance_and_its_role_in_clinical_oncology"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#EasternBlotting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Eastern_Blot_Analysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Efflux_Bioassay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Elisabeth_Paietta"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Epirubicin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Etoposide"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#European_Journal_of_Pharmaceutical_Sciences"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ExperimentalStudy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Experimental_Study"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Finding9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Flavopiridol"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Fluorochrome-labeled_anti-CD_antibodies"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Fluorouracil"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Functional_Assay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Functional_Bioassay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Gastrointestinal_stromal_tumour_GIST_cell_lines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Gefitinib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Gergely_SzakÃ¡cs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Growth_inhibition_assays"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#HTB_10_HTB_11_HTB_38"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Head_and_neck_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#High-risk_MDS_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#I._PASTAN"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#IL-2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Iamivudine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Idarubicine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Idarubicinol"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Ifosfamide"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Ikumi_Tamai"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Imatinib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Immunosuppressant_cyclosporin_A"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Indolocarbazole"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#International_Clinical_Cytometry_Society"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Invitrogen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Jill_K._Paterson"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#John_F._Marcelletti"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Joseph_A._Ludwig"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#K._UEDA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#KB-3-1_KB-8-5_KB-V1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Kazuki_Fukuchi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Keiichi_Kawai"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Kodai_Nishi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#L._AUSTIN_DOYLE"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#LYNNE_V._ABRUZZO"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Larry_D._Cripe"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Lawrence_D._Mayer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Leukaemia"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Leukotriene_C4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Levels_of_mdrl_mRNA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Lung_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Lymphoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#M._M._GOTTESMAN"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MCF-7_human_breast_carcinoma_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MDR2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MRP8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Macmillan_Magazines_Ltd"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Masato_Kobayashi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Melanoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Melanoma_cell_line"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Methotrexate"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Michael_M._Gottesman"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Mitomycin_C"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multidrug_Resistance_Monitoring_in_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Multiple_chemotherapeutic_agents"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MutationResult9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Myeloma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#NSCLC"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#NSCLC_cell_lines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#NSCLC_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#National_Cancer_Institute"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Nature_Publishing_Group"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Neck_squamous_cell_carcinoma_cell_lines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Neuroblastoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Neuroblastoma_Cell"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Neuroepithelioma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Nilotinib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Non_Smallcell_Lung_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Northern_analysis_of_the_expression_of_BCRP_mRNA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ObservationalStudy"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Observational_Study"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Ovarian_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Paclitaxel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Pancreatic_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Pancreatic_cancer_cell_lines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Patrick_G._Johnston"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Peripheral_blood_lymphocytes"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Pheochromocytoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Podophyllotoxin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Podophyllotoxin-etoposide_teniposide"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Poor-risk_acute_leukaemia_samples"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Prazocin"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Proc._Nati._Acad._Sci._USA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Promega_Biotec"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#RT-PCR_assay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Rajesh_Krishna"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Refractory_AML_high-risk_MDS_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Relapsed_and_refractory_AML_sample"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Renal_cell_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Review_Study"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Rhabdomyosarcoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Role_of_P-GP_in_MDR"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Ryuichi_Nishii"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Sandra_Van_Schaeybroeck"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Sarcoma"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Slot_Blot_Analysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Small_Cell_Lung_Cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Southern_Blot_Analysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#StatisticalAnalysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Study"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Sulforhodamine-B_cytotoxicity_assay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Surrogate_Assay"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Susan_E._Bates"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TAMMY_KROGMANN"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Takafumi_Tsujiuchi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Takeo_Nakanishi"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TargetingMethod9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Taurocholate"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Taxenes-paclitaxel_docetaxel"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Teniopside"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Testicular_cancer"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TissueLocalization9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Tito_Fojo"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Topotecan"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Trastuzumab"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome10"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome11"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome12"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome13"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome14"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome15"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome16"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome17"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome18"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome19"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome2"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome20"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome3"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome4"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome5"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome6"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome7"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome8"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#TreatmentOutcome9"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#VAD"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Vemurafenib"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Verapamil"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Vincristine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Vindesine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#WEIDONG_YANG"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Western_Blot_Analysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#YONGMING_GAO"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Yuya_Okui"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Zidovudine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Zosuquidar"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#antibody-mediated_cytolysis_experiment"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#cDNA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ex_vivo"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasAssayMethod"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasDrugEffects"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasEligibilityCriteria"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasExperimentalResult"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasFindings"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasMutationResult"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasSuggestion"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#hasTissueLocalization"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#identify_and_overcome_underlying_mechanisms_of_resistance"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#in_silico"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#in_vitro"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#in_vivo"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#inhibitors_NB-506_J-107088"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#mdr1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#topoisomerase_I"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useCellLine"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useDrug"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useGene"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useProbe"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useReagent"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useSpecimen"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#useStatisticalAnalysis"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#10_patients_with_acute_lymphocytic_leukemia"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#50_patients_with_newly_diagnosed_AML"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#795-bp_cDNA"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#99mTc-labeled_compounds_were_exported_via_MRP2â4_and_BCRP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CAV/EP"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CD34+_Leukemic_Blasts"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#CD56+"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#ERBB2âamplified_breast_cancer_cell_lines"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#PGP/MDR1"/>
    </Declaration>
    <Declaration>
        <NamedIndividual IRI="#Springer_Science+Business_Media_LLC"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:coverage"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:creator"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:format"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:identifier"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:language"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:publisher"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:rights"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:source"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:subject"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="dc:type"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:abstract"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:accessRights"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:alternative"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:available"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:bibliographicCitation"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:conformsTo"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:contributor"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:coverage"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:created"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:date"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:dateAccepted"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:dateCopyrighted"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:dateSubmitted"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:extent"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:format"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:hasFormat"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:hasPart"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isFormatOf"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isPartOf"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isReferencedBy"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isReplacedBy"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isRequiredBy"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:isVersionOf"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:language"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:license"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:medium"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:references"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:relation"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:replaces"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:requires"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:rights"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:source"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:spatial"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:subject"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:tableOfContents"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:temporal"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:type"/>
    </Declaration>
    <Declaration>
        <AnnotationProperty abbreviatedIRI="terms:valid"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:Box"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:ISO3166"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:ISO639-2"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:ISO639-3"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:Period"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:Point"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:RFC1766"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:RFC3066"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:RFC4646"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:RFC5646"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:URI"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="terms:W3CDTF"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="xsd:date"/>
    </Declaration>
    <Declaration>
        <Datatype abbreviatedIRI="xsd:gYear"/>
    </Declaration>
    <SubClassOf>
        <Class abbreviatedIRI="terms:AgentClass"/>
        <Class abbreviatedIRI="rdfs:Class"/>
    </SubClassOf>
    <SubClassOf>
        <Class abbreviatedIRI="terms:LicenseDocument"/>
        <Class abbreviatedIRI="terms:RightsStatement"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Assay"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#AssayKit"/>
        <Class IRI="#Assay"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#AssayMethod"/>
        <Class IRI="#Assay"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#BlotAnalysis"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Cell"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#CellLine"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Chemical"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ClinicalProblem"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ClinicalStudy"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ClinicalTrial"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Disease"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Drug"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#EasternBlotting"/>
        <Class IRI="#BlotAnalysis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ExperimentKit"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ExperimentMaterial"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ExperimentSetting"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ExperimentalStudy"/>
        <Class IRI="#StudyDesign"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Gene"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Hypothesis"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Investigation"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#NorthernBlotting"/>
        <Class IRI="#BlotAnalysis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ObservationalStudy"/>
        <Class IRI="#StudyDesign"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Patient"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Probe"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Reagent"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ReviewStudy"/>
        <Class IRI="#StudyDesign"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#SouthernBlotting"/>
        <Class IRI="#BlotAnalysis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Specimen"/>
        <Class IRI="#ExperimentMaterial"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#StatisticalAnalysis"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#StudyDesign"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#Treatment"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#WesternBlotting"/>
        <Class IRI="#BlotAnalysis"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#ex_vivo"/>
        <Class IRI="#ExperimentSetting"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#in_silico"/>
        <Class IRI="#ExperimentSetting"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#in_vitro"/>
        <Class IRI="#ExperimentSetting"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#in_vivo"/>
        <Class IRI="#ExperimentSetting"/>
    </SubClassOf>
    <SubClassOf>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <Class IRI="#Study"/>
    </SubClassOf>
    <DisjointClasses>
        <Class IRI="#AssayKit"/>
        <Class IRI="#AssayMethod"/>
        <Class IRI="#CellLine"/>
        <Class IRI="#Chemical"/>
        <Class IRI="#Drug"/>
        <Class IRI="#EasternBlotting"/>
        <Class IRI="#ExperimentalStudy"/>
        <Class IRI="#Gene"/>
        <Class IRI="#NorthernBlotting"/>
        <Class IRI="#ObservationalStudy"/>
        <Class IRI="#Probe"/>
        <Class IRI="#Reagent"/>
        <Class IRI="#ReviewStudy"/>
        <Class IRI="#SouthernBlotting"/>
        <Class IRI="#WesternBlotting"/>
        <Class IRI="#ex_vivo"/>
        <Class IRI="#in_silico"/>
        <Class IRI="#in_vitro"/>
        <Class IRI="#in_vivo"/>
    </DisjointClasses>
    <ClassAssertion>
        <Class abbreviatedIRI="terms:AgentClass"/>
        <NamedIndividual abbreviatedIRI="terms:Agent"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:DCMIType"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:DDC"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:IMT"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:LCC"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:LCSH"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:MESH"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:NLM"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:TGN"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <NamedIndividual abbreviatedIRI="terms:UDC"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#A._T._FoJo"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#ABCA2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#ABC_genes"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#ADE"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#ALL"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#AML"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#AML_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#ARUN_K._RISHI"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Accumulation_Bioassay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Actinomycin_D"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Acute_lymphoblastic_leukemia"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Adrenocortical_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Advanced_and_recurrent_breast_cancer_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#American_Type_Culture_Collection"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Anthracyclines-doxorubucin_daunorubicin_epirubicin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Anthranilic-acid-based_drug"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Asuka_Mizutani"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#BBR3390"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#BD_Biosciences_La_Jolla_CA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#BH3_profiling"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#BH3_profiling_method"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Bevacizumab"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#StatisticalAnalysis"/>
        <NamedIndividual IRI="#Blast_populations_in_the_two_bioassays"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Bone_marrow_aspirates"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Bortezomib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Branimir_I._Sikic"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Breast_cancer_samples"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#CAVE"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#CCL_127__PC12"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#CI1033"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#CLONTECH"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#CML"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Caitriona_Holohan"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#Cancer_Cell_International"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Treatment"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Cancer_drug_resistance_an_evolving_paradigm"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Cancer_drug_resistance_an_evolving_paradigm"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Carboplatin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Catherine_Booth-Genthe"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Cetuximab"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Treatment"/>
        <NamedIndividual IRI="#Chemotherapy"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Treatment"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Cheol-Hee_Choi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Clonogenic_survival_assays"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Colchicine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Colerectal_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Colon_Tumor"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Colon_carcinoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Crizotinib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Cyclosporine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Cytarabine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#D._G._POPLACK"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#D._J._SLAMON"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#DOUGLAS_D._ROSS"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Daniel_B._Longley"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Dasatinib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Daunomycin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ExperimentKit"/>
        <NamedIndividual IRI="#Delta_RNA_Fingerprinting_kit"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#Describe_various_approaches_to_combating_multidrug-resistant_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Reagent"/>
        <NamedIndividual IRI="#DiOC2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Treatment"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Doxorubicin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#Drosophila_white_gene"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalProblem"/>
        <NamedIndividual IRI="#Drug_Resistance"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#Drug_resistance_and_its_role_in_clinical_oncology"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#EasternBlotting"/>
        <NamedIndividual IRI="#Eastern_Blot_Analysis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Efflux_Bioassay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Elisabeth_Paietta"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Epirubicin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Etoposide"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#European_Journal_of_Pharmaceutical_Sciences"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ExperimentalStudy"/>
        <NamedIndividual IRI="#Experimental_Study"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Flavopiridol"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Reagent"/>
        <NamedIndividual IRI="#Fluorochrome-labeled_anti-CD_antibodies"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Fluorouracil"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Functional_Assay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Functional_Bioassay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Treatment"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Gastrointestinal_stromal_tumour_GIST_cell_lines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Gefitinib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Gergely_SzakÃ¡cs"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Growth_inhibition_assays"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#HTB_10_HTB_11_HTB_38"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Head_and_neck_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#High-risk_MDS_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#I._PASTAN"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#IL-2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Iamivudine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Idarubicine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Idarubicinol"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Ifosfamide"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Ikumi_Tamai"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Imatinib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Immunosuppressant_cyclosporin_A"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Indolocarbazole"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#International_Clinical_Cytometry_Society"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#Invitrogen"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Jill_K._Paterson"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#John_F._Marcelletti"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Joseph_A._Ludwig"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#K._UEDA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#KB-3-1_KB-8-5_KB-V1"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Kazuki_Fukuchi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Keiichi_Kawai"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Kodai_Nishi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#L._AUSTIN_DOYLE"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#LYNNE_V._ABRUZZO"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Larry_D._Cripe"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Lawrence_D._Mayer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Leukaemia"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Leukotriene_C4"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#Levels_of_mdrl_mRNA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Lymphoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#M._M._GOTTESMAN"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#MCF-7_human_breast_carcinoma_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MDR2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP1"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP2"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP3"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP4"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP5"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP6"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP7"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#MRP8"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#Macmillan_Magazines_Ltd"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Agent"/>
        <NamedIndividual IRI="#Macmillan_Magazines_Ltd"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Masato_Kobayashi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Melanoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Melanoma_cell_line"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Methotrexate"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Michael_M._Gottesman"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Mitomycin_C"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Multidrug_Resistance_Monitoring_in_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalProblem"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalProblem"/>
        <NamedIndividual IRI="#Multiple_chemotherapeutic_agents"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Myeloma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#NSCLC"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#NSCLC_cell_lines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#NSCLC_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#National_Cancer_Institute"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#Nature_Publishing_Group"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Agent"/>
        <NamedIndividual IRI="#Nature_Publishing_Group"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Neck_squamous_cell_carcinoma_cell_lines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Neuroblastoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Neuroblastoma_Cell"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Neuroepithelioma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Nilotinib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Non_Smallcell_Lung_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#NorthernBlotting"/>
        <NamedIndividual IRI="#Northern_analysis_of_the_expression_of_BCRP_mRNA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ObservationalStudy"/>
        <NamedIndividual IRI="#Observational_Study"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Ovarian_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Paclitaxel"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Pancreatic_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#Pancreatic_cancer_cell_lines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Patient"/>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Patrick_G._Johnston"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Peripheral_blood_lymphocytes"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Patient"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Patient"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Pheochromocytoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Podophyllotoxin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Podophyllotoxin-etoposide_teniposide"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Poor-risk_acute_leukaemia_samples"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Prazocin"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#Proc._Nati._Acad._Sci._USA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Agent"/>
        <NamedIndividual IRI="#Proc._Nati._Acad._Sci._USA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Organization"/>
        <NamedIndividual IRI="#Promega_Biotec"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#RT-PCR_assay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Rajesh_Krishna"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Refractory_AML_high-risk_MDS_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Specimen"/>
        <NamedIndividual IRI="#Relapsed_and_refractory_AML_sample"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Renal_cell_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ReviewStudy"/>
        <NamedIndividual IRI="#Review_Study"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Rhabdomyosarcoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalProblem"/>
        <NamedIndividual IRI="#Role_of_P-GP_in_MDR"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Ryuichi_Nishii"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Sandra_Van_Schaeybroeck"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Sarcoma"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#BlotAnalysis"/>
        <NamedIndividual IRI="#Slot_Blot_Analysis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Small_Cell_Lung_Cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#SouthernBlotting"/>
        <NamedIndividual IRI="#Southern_Blot_Analysis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Sulforhodamine-B_cytotoxicity_assay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Assay"/>
        <NamedIndividual IRI="#Surrogate_Assay"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Susan_E._Bates"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#TAMMY_KROGMANN"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Takafumi_Tsujiuchi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Takeo_Nakanishi"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Taurocholate"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Taxenes-paclitaxel_docetaxel"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Teniopside"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Disease"/>
        <NamedIndividual IRI="#Testicular_cancer"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Tito_Fojo"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Topotecan"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Trastuzumab"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#VAD"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Vemurafenib"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Verapamil"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Vincristine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Vindesine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#WEIDONG_YANG"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#WesternBlotting"/>
        <NamedIndividual IRI="#Western_Blot_Analysis"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#YONGMING_GAO"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="foaf:Person"/>
        <NamedIndividual IRI="#Yuya_Okui"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Zidovudine"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#Zosuquidar"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#antibody-mediated_cytolysis_experiment"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Probe"/>
        <NamedIndividual IRI="#cDNA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ex_vivo"/>
        <NamedIndividual IRI="#ex_vivo"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#identify_and_overcome_underlying_mechanisms_of_resistance"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#in_silico"/>
        <NamedIndividual IRI="#in_silico"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#in_vitro"/>
        <NamedIndividual IRI="#in_vitro"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#in_vivo"/>
        <NamedIndividual IRI="#in_vivo"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#inhibitors_NB-506_J-107088"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#mdr1"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#topoisomerase_I"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Patient"/>
        <NamedIndividual IRI="#10_patients_with_acute_lymphocytic_leukemia"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Patient"/>
        <NamedIndividual IRI="#50_patients_with_newly_diagnosed_AML"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Probe"/>
        <NamedIndividual IRI="#795-bp_cDNA"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#99mTc-labeled_compounds_were_exported_via_MRP2â4_and_BCRP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#levels_of_mdr1_mRNA"/>
        <NamedIndividual IRI="#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Drug"/>
        <NamedIndividual IRI="#CAV/EP"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#CD34+_Leukemic_Blasts"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#CD56+"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#ClinicalStudy"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#CellLine"/>
        <NamedIndividual IRI="#ERBB2âamplified_breast_cancer_cell_lines"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publication"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="bibo:Article"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class IRI="#Gene"/>
        <NamedIndividual IRI="#PGP/MDR1"/>
    </ClassAssertion>
    <ClassAssertion>
        <Class abbreviatedIRI="terms1:Publisher"/>
        <NamedIndividual IRI="#Springer_Science+Business_Media_LLC"/>
    </ClassAssertion>
    <SameIndividual>
        <NamedIndividual IRI="#Daunomycin"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </SameIndividual>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#antibody-mediated_cytolysis_experiment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#CAVE"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Cyclosporine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Cytarabine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Epirubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Etoposide"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#IL-2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Paclitaxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#VAD"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#Vindesine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
        <NamedIndividual IRI="#CAV/EP"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Leukaemia"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Non_Smallcell_Lung_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Small_Cell_Lung_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigatesProblem"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#Drug_Resistance"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#AML_sample"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Advanced_and_recurrent_breast_cancer_sample"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
        <NamedIndividual IRI="#AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
        <NamedIndividual IRI="#Leukaemia"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigatesProblem"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#BH3_profiling_method"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Gastrointestinal_stromal_tumour_GIST_cell_lines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Melanoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Pancreatic_cancer_cell_lines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#ERBB2âamplified_breast_cancer_cell_lines"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Bevacizumab"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Bortezomib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Cetuximab"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Crizotinib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Dasatinib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Gefitinib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Nilotinib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Trastuzumab"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BH3_profiling"/>
        <NamedIndividual IRI="#Vemurafenib"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#BH3_profiling_method"/>
        <NamedIndividual IRI="#Functional_Assay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#Bone_marrow_aspirates"/>
        <NamedIndividual IRI="#50_patients_with_newly_diagnosed_AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Breast_cancer_samples"/>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <NamedIndividual IRI="#Actinomycin_D"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <NamedIndividual IRI="#Doxorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <NamedIndividual IRI="#Mitomycin_C"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <NamedIndividual IRI="#Vincristine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <NamedIndividual IRI="#Peripheral_blood_lymphocytes"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Cancer_drug_resistance_an_evolving_paradigm"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#AML_sample"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#Advanced_and_recurrent_breast_cancer_sample"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#NSCLC_sample"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#Poor-risk_acute_leukaemia_samples"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#Refractory_AML_high-risk_MDS_sample"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <NamedIndividual IRI="#Relapsed_and_refractory_AML_sample"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#Colon_carcinoma"/>
        <NamedIndividual IRI="#National_Cancer_Institute"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#Delta_RNA_Fingerprinting_kit"/>
        <NamedIndividual IRI="#CLONTECH"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#DiOC2"/>
        <NamedIndividual IRI="#Invitrogen"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
        <NamedIndividual IRI="#Multidrug_Resistance_Monitoring_in_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <NamedIndividual IRI="#Leukotriene_C4"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <NamedIndividual IRI="#Taurocholate"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#Leukaemia"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#Myeloma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <NamedIndividual IRI="#ABC_transporters_and_in_vitro_MDR"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#Actinomycin_D"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#Anthracyclines-doxorubucin_daunorubicin_epirubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#Colchicine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#Methotrexate"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#Podophyllotoxin-etoposide_teniposide"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP3"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP4"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP5"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP6"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP7"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#MRP8"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <NamedIndividual IRI="#mdr1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia"/>
        <NamedIndividual IRI="#Analysis_of_leukemic_blast_MDR_function"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Adrenocortical_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Colon_Tumor"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Neuroblastoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Neuroepithelioma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Pheochromocytoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Rhabdomyosarcoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigatesProblem"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#Multiple_chemotherapeutic_agents"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#Fluorochrome-labeled_anti-CD_antibodies"/>
        <NamedIndividual IRI="#BD_Biosciences_La_Jolla_CA"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
        <NamedIndividual IRI="#Breast_cancer_samples"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasStudyDesign"/>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
        <NamedIndividual IRI="#Review_Study"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
        <NamedIndividual IRI="#AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#MCF-7_human_breast_carcinoma_cells"/>
        <NamedIndividual IRI="#National_Cancer_Institute"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#ALL"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#CML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Colerectal_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Head_and_neck_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Lymphoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Melanoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#NSCLC"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Ovarian_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#Pancreatic_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <NamedIndividual IRI="#BH3_profiling"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Colerectal_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Myeloma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Ovarian_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Renal_cell_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigatesProblem"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Role_of_P-GP_in_MDR"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
        <NamedIndividual IRI="#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#NSCLC_sample"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfrom"/>
        <NamedIndividual IRI="#Neuroblastoma_Cell"/>
        <NamedIndividual IRI="#American_Type_Culture_Collection"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
        <NamedIndividual IRI="#Adrenocortical_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#has_Treatment"/>
        <NamedIndividual IRI="#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Peripheral_blood_lymphocytes"/>
        <NamedIndividual IRI="#10_patients_with_acute_lymphocytic_leukemia"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <NamedIndividual IRI="#AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#has_Treatment"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Colerectal_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Lung_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Myeloma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Ovarian_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Renal_cell_cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#has_Treatment"/>
        <NamedIndividual IRI="#Phase_II_clinical_trials_in_patients"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Poor-risk_acute_leukaemia_samples"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
        <NamedIndividual IRI="#Northern_analysis_of_the_expression_of_BCRP_mRNA"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
        <NamedIndividual IRI="#RT-PCR_assay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
        <NamedIndividual IRI="#Sulforhodamine-B_cytotoxicity_assay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasTreatment"/>
        <NamedIndividual IRI="#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
        <NamedIndividual IRI="#Surrogate_Assay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#RT-PCR_assay"/>
        <NamedIndividual IRI="#Drosophila_white_gene"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Refractory_AML_high-risk_MDS_sample"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <NamedIndividual IRI="#Relapsed_and_refractory_AML_sample"/>
        <NamedIndividual IRI="#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasStudyDesign"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
        <NamedIndividual IRI="#Review_Study"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#The_physiological_functions_and_structures_of_ABC_transporters"/>
        <NamedIndividual IRI="#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasTreatment"/>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
        <NamedIndividual IRI="#Daunomycin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useProbe"/>
        <NamedIndividual IRI="#Vesicle_transport_experiments"/>
        <NamedIndividual IRI="#cDNA"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#CD34+_Leukemic_Blasts"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#Zosuquidar"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useReagent"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#DiOC2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useReagent"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#Fluorochrome-labeled_anti-CD_antibodies"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useSpecimen"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <NamedIndividual IRI="#Bone_marrow_aspirates"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasTreatment"/>
        <NamedIndividual IRI="#antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#antibody-mediated_cytolysis_experiment"/>
        <NamedIndividual IRI="#Functional_Assay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Slot_Blot_Analysis"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasTreatment"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#CCL_127__PC12"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Colon_carcinoma"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#HTB_10_HTB_11_HTB_38"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#KB-3-1_KB-8-5_KB-V1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Actinomycin_D"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Doxorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Mitomycin_C"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#Vincristine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#mdr1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useProbe"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <NamedIndividual IRI="#cDNA"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#CD56+"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Anthranilic-acid-based_drug"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Immunosuppressant_cyclosporin_A"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Paclitaxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#Verapamil"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#ABCA2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MDR2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP1"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP2"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP3"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP4"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP5"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useGene"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <NamedIndividual IRI="#MRP6"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#10_patients_with_acute_lymphocytic_leukemia"/>
        <NamedIndividual IRI="#Leukaemia"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#has_Treatment"/>
        <NamedIndividual IRI="#10_patients_with_acute_lymphocytic_leukemia"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasDisease"/>
        <NamedIndividual IRI="#50_patients_with_newly_diagnosed_AML"/>
        <NamedIndividual IRI="#AML"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#BBR3390"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#CI1033"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Doxorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Epirubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Flavopiridol"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Iamivudine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Idarubicinol"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Indolocarbazole"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Methotrexate"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Prazocin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Topotecan"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#Zidovudine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#BCRP_substrate/inhibitors"/>
        <NamedIndividual IRI="#topoisomerase_I"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
        <NamedIndividual IRI="#Accumulation_Bioassay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
        <NamedIndividual IRI="#Efflux_Bioassay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useAssay"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
        <NamedIndividual IRI="#Functional_Bioassay"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
        <NamedIndividual IRI="#Comparative_CD34+_blast_responses_were_examined"/>
        <NamedIndividual IRI="#Blast_populations_in_the_two_bioassays"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#investigate"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
        <NamedIndividual IRI="#Breast_Cancer"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#performsExperiment"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentKit"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Delta_RNA_Fingerprinting_kit"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#RNA_Fingerprinting"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useCellLine"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#MCF-7_human_breast_carcinoma_cells"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Daunorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Doxorubicin"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Mitoxantrone"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Paclitaxel"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useDrug"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#Vincristine"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#useProbe"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <NamedIndividual IRI="#795-bp_cDNA"/>
    </ObjectPropertyAssertion>
    <ObjectPropertyAssertion>
        <ObjectProperty IRI="#addressesStudy"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
    </ObjectPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">2005</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal"/>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis. One strategy for reversal of the resistance of tumor cells
expressing ABC transporters is combined use of anticancer drugs with chemosensitizers. In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#ABC_transporters_in_human_cancers"/>
        <Literal>MULTIDRUG RESISTANCE IN CANCER</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">1998</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells"/>
        <Literal xml:lang="en">MCF-7yAdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in
MCF-7yAdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length
BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123
in the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7yAdrVp human breast cancer cells.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#AssayKit"/>
        <Literal xml:lang="en">AssayKit</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#AssayMethod"/>
        <Literal xml:lang="en">AssayMethod</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#treatmentOutcome"/>
        <NamedIndividual IRI="#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <Literal xml:lang="en">Vinca alkaloid, doxorubicin, or actinomycin D might not be effective in the therapy of pheochromocytoma.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Cancer_drug_resistance_an_evolving_paradigm"/>
        <Literal xml:lang="en">Resistance to chemotherapy and molecularly targeted therapies is a major
problem facing current cancer research. The mechanisms of resistance to âclassicalâ cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug
resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
        <Literal xml:lang="en">2018</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer"/>
        <Literal xml:lang="en">Background Little is known about the affinity and stability of
99mTc-labeled 2-methoxyisobutylisonitrile (99mTc-MIBI) and
tetrofosmin (99mTc-TF) for imaging of multiple drug resistance
transporters in cancer. We examined the affinity of 99mTc-labeled
compounds for these transporters and their stability.
Methods 99mTc-MIBI and 99mTc-TF were incubated in vesicles
expressing P-glycoprotein (MDR1), multidrug resistanceassociated
protein (MRP)1â4, or breast cancer resistance protein
with and without verapamil (MDR1 inhibitor) or MK-
571 (MRP inhibitor). Time activity curves of 99mTc-labeled
compounds were established using SK-N-SH neuroblastoma,
SK-MEL-28 melanoma, and PC-3 prostate adenocarcinoma
cell lines, and transporter expression of multiple drug resistance
was measured in these cells. The stability was evaluated.
Results In vesicles, 99mTc-labeled compounds had affinity for
MDR1 and MRP1. 99mTc-TF had additional affinity for
MRP2 and MRP3. In SK-N-SH cells expressing MDR1 and
MRP1, MK-571 produced the highest uptake of both 99mTclabeled
compounds. 99mTc-MIBI uptake with inhibitors was
higher than 99mTc-TF uptake with inhibitors. 99mTc-TF was
taken up more in SK-MEL-28 cells expressing MRP1 and
MRP2 than PC-3 cells expressing MRP1 and MRP3. 99mTc-
MIBI was metabolized, whereas 99mTc-TF had high stability.
Conclusion 99mTc-MIBI is exported via MDR1 and MRP1
(MRP1 &gt; MDR1) at greater levels and more quickly compared
to 99mTc-TF, which is exported via MDR1 and MRP1â3
(MRP1 &gt; MDR1; MRP1, 2 &gt;MRP3). Because 99mTc-MIBI
is metabolized, clinical imaging for monitoring MDR and
shorter examination times may be possible with an earlier scanning
time on late phase imaging. 99mTc-TF has high stability
and accurately reflects the function of MDR1 and MRP1â3.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#treatmentOutcome"/>
        <NamedIndividual IRI="#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <Literal xml:lang="en">There was increased intracellular
accumulation of doxorubicin as was evidenced using
confocal microscopy and reduced toxicity compared to the
free (unencapsulated) doxorubicin.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasMutationResult"/>
        <NamedIndividual IRI="#Drug_Resistance"/>
        <Literal>Dubin-Johnson syndrome</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasTissueLocalization"/>
        <NamedIndividual IRI="#Drug_Resistance"/>
        <Literal>Liver, kidney, intestine, adrenal glands, pancreas, lung, ovary</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#name"/>
        <NamedIndividual IRI="#Drug_Resistance"/>
        <Literal>Drug Resistance</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <Literal>Targeting multidrug resistance in cancer</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#EasternBlotting"/>
        <Literal xml:lang="en">EasternBlotting</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia"/>
        <Literal xml:lang="en">Background: Multidrug resistance (MDR) transporter proteins such as P-glycoprotein (P-gp) efflux a variety
of chemotherapeutic drugs from acute myeloid leukemia (AML) blasts leading to clinical drug resistance.
Methods: This study examined heterogeneity of MDR functional efflux by AML blasts using two flow cytometry
bioassays. Bone marrow specimens (N = 50) from elderly patients with newly diagnosed AML were analyzed
for CD34+ blasts with MDR efflux function. Efflux was measured with a fluorescent dye (DiOC2) as a
surrogate for oncology drugs that are substrates for MDR efflux. P-gp-mediated efflux was differentiated from
non-P-gp MDR activities using zosuquidar, a highly selective P-gp modulator. The bioassays included a
zosuquidar-dependent DiOC2 accumulation bioassay that measured only P-gp. The second method, termed the
efflux bioassay, could detect P-gp and other non-P-gp efflux depending on bioassay culture conditions.
Results: Sixty-two percent of the specimens were considered positive for blasts with P-gp function, and
26% of such P-gp-positive specimens also exhibited zosuquidar-resistant (i.e., non-P-gp) MDR efflux activity;
37% of P-gp-negative AML blast specimens displayed zosuquidar-resistant MDR function in the efflux
bioassay.
Conclusions: These results confirm the heterogeneous nature of MDR efflux pumps in AML blasts, and provide
support for the hypothesis that non-P-gp MDR contributed to negative results with zosuquidar in AML trials
like ECOG-ACRIN E3999.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#ExperimentalStudy"/>
        <Literal xml:lang="en">ExperimentalStudy</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <Literal>Expression of a multidrug-resistance gene in human tumors and tissues</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasSuggestion"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene"/>
        <Literal>Some cases of colon cancer, increased expression of the mdr1 gene might be involved in the intrinsic resistance of these tumors to chemotherapeutic agents.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">1987</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues"/>
        <Literal>The identification and cloning of a segment of a human multidrug resistance gene (mdrl) was reported recently. To examine the molecular basis of one type of multidrug resistance, we have prepared RNA from human tumors and normal tissues and measured their content of mdrl RNA. We find that the mdrl gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at
intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues. The mdrl gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon. In addition, increased expression was detected in a few tumors at the time of relapse following initial chemotherapy. Although controlled clinical studies will be required, our results suggest that measurement of mdrl RNA may prove to be a valuable tool in the design of chemotherapy protocols.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#failureReason"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
        <Literal>PGP expression increased after therapy and was associated with a greater likelihood of treatment failure.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#treatmentOutcome"/>
        <NamedIndividual IRI="#Functions_of_ABC_transporters_in_Chemotherapy"/>
        <Literal>Toxicity</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Macmillan_Magazines_Ltd"/>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Macmillan Magazines Ltd</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <Literal>Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">2000</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs"/>
        <Literal xml:lang="en">In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions. In addition,
its role in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in
various studies. This overview presents a background on some of the commonly documented mechanisms of multidrug resistance (MDR),
reversal using modulators of MDR, followed by a discussion on the functional aspects of P-GP in the context of the pharmacokinetic
interactions when multiple agents are coadministered. While adverse pharmacokinetic interactions have been documented with first and
second generation MDR modulators, certain newer agents of the third generation class of compounds have been less susceptible in
eliciting pharmacokinetic interactions. Although the review focuses on P-GP and the pharmacology of MDR reversal using MDR
modulators, relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution,
clearance, and interactions) will also be discussed.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">2003</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP"/>
        <Literal xml:lang="en">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members
suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance. In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found. The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells. BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2. Like all members of the ABC G (white) subfamily, BCRP is a half transporter. Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that
functional BCRP is a homodimer. BCRP maps to chromosome 4q22, downstream from a TATA-less promoter. The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and
indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors. Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482. Potent and
specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition. Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics. BCRP expression has also been demonstrated in pluripotential âside populationâ stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell
phenotype. Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers. More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional
assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Nature_Publishing_Group"/>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Nature Publishing Group</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#ObservationalStudy"/>
        <Literal xml:lang="en">ObservationalStudy</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Proc._Nati._Acad._Sci._USA"/>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Proc. Nati. Acad. Sci. USA</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#StatisticalAnalysis"/>
        <Literal xml:lang="en">StatisticalAnalysis</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#Study"/>
        <Literal xml:lang="en">Study</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasAssayMethod"/>
        <NamedIndividual IRI="#Surrogate_Assay"/>
        <Literal xml:lang="en">This assay uses flow cytometry to test the ability of human CD56+ cells â
which express high levels of the efflux pump P-glycoprotein (PGP) â to retain the PGP substrate rhodamine after exposure to the efflux pump inhibitor PSC-833.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">2006</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#Targeting_multidrug_resistance_in_cancer"/>
        <Literal xml:lang="en">Effective treatment of metastatic cancers usually requires the use of toxic
chemotherapy. In most cases, multiple drugs are used, as resistance to single agents occurs almost universally. For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chemical structures â multidrug resistance â has been a major goal of cancer biologists during the past 35 years. Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters. We describe various approaches
to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasExperimentalResult"/>
        <NamedIndividual IRI="#Zosuquidar_AML_experiments"/>
        <Literal xml:lang="en">50 AML specimens for MDR function
using zosuquidar, a P-gp-selective modulator, and two
ex vivo leukemic blast bioassays confirms the heterogeneous
nature of MDR efflux pump function by AML
blasts. Moreover, it supports the supposition that function
of multiple transporters could have circumvented
or obscured efficacy of P-gp modulators in AML clinical
trials like E3999 with zosuquidar.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasAssayMethod"/>
        <Literal xml:lang="en">hasAssayMethod</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasDrugEffects"/>
        <Literal xml:lang="en">hasDrugEffects</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasEligibilityCriteria"/>
        <Literal xml:lang="en">hasEligibilityCriteria</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasExperimentalResult"/>
        <Literal xml:lang="en">hasExperimentalResult</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasFindings"/>
        <Literal xml:lang="en">hasFindings</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasMutationResult"/>
        <Literal xml:lang="en">hasMutationResult</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasSuggestion"/>
        <Literal xml:lang="en">hasSuggestion</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#hasTissueLocalization"/>
        <Literal xml:lang="en">hasTissueLocalization</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasExperimentalResult"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <Literal xml:lang="en">Expression of mdr1 in Tumors from Untreated and Treated Patients</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#name"/>
        <NamedIndividual IRI="#mdr1_gene_expression"/>
        <Literal xml:lang="en">Mdr1 Hybridization Probes, RNA Extraction, Electrophoresis</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#name"/>
        <NamedIndividual IRI="#multidrug_resistance_to_cancer_cells"/>
        <Literal>Transfection Experiments</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useCellLine"/>
        <Literal xml:lang="en">useCellLine</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useDrug"/>
        <Literal xml:lang="en">useDrug</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useGene"/>
        <Literal xml:lang="en">useGene</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useProbe"/>
        <Literal xml:lang="en">useProbe</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useReagent"/>
        <Literal xml:lang="en">useReagent</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useSpecimen"/>
        <Literal xml:lang="en">Specimen that are used as material in experimental study.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useSpecimen"/>
        <Literal xml:lang="en">useSpecimen</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="foaf:name"/>
        <NamedIndividual IRI="#useStatisticalAnalysis"/>
        <Literal xml:lang="en">useStatisticalAnalysis</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
        <Literal>A multidrug resistance transporter from human MCF-7 breast cancer cells</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasSuggestion"/>
        <NamedIndividual IRI="#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
        <Literal xml:lang="en">The presence of the phosphopantetheine attachment site on BCRP suggests
that BCRP may be part of a multiprotein complex.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasExperimentalResult"/>
        <NamedIndividual IRI="#MCF-7/AdrVp_comparison"/>
        <Literal xml:lang="en">Sensitivity of selected MCF-7 sublines to antineoplastic agents determined by sulforhodamine-B cytotoxicity assay (21). Experiments such as those
displayed in Figure 4D were used to obtain the LC50. For each drug and cell type, the table displays the median LC50 and range of LC50 measurements
(nM), the number of experimental determinations of LC50 that were performed (N), and the resistance factor (RF). The RF was calculated by
dividing the median LC50 for a given drug against a transfected cell line by the median LC50 of that drug against nontransfected MCF-7yW cells.
For each drug tested, the LC50 for the BCRP-transfected cells was examined for statistically significant difference from the LC50 of MCF-7yW or
MCF-7ypcDNA3 by the MannâWhitney test, using MINITAB statistical software MINITAB release 8 extended, Minitab, State College, PA) and a 95%
confidence interval. The values of P for the statistically significant differences are as follows Mitoxantrone: MCF-7yW vs. MCF-7yBCRPclone6,
P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.0058, MCF-7ypcDNA3 vs. MCF-71BCRPclone6, P 5 0.0142, MCF-7ypcDNA3 vs.
MCF-7yBCRPclone8, P 5 0.0081; daunorubicin: MCF-7yW vs. MCF-7yBCRPclone6, P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5
0.0058, MCF-7ypcDNA3 vs. MCF-7yBCRPclone6, P 5 0.0195, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0163; doxorubicin: MCF-7yW
vs. MCF-7yBCRPclone6, P 5 0.0373, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.02, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0304;
cis-platin: MCF-7yW vs. MCF-7yBCRPclone19, P 5 0.0497.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="terms1:publicationYear"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#gYear">2002</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
        <Literal>Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs â a trait known as multidrug resistance â remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</Literal>
    </DataPropertyAssertion>
    <DataPropertyAssertion>
        <DataProperty IRI="#hasTitle"/>
        <NamedIndividual IRI="#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS"/>
        <Literal xml:lang="en">MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS</Literal>
    </DataPropertyAssertion>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms1:relation"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:alternative"/>
        <ObjectProperty abbreviatedIRI="terms:title"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:creator"/>
        <ObjectProperty abbreviatedIRI="terms:contributor"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:hasPart"/>
        <ObjectProperty abbreviatedIRI="terms:relation"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:isPartOf"/>
        <ObjectProperty abbreviatedIRI="terms:relation"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:isReferencedBy"/>
        <ObjectProperty abbreviatedIRI="terms:relation"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:isVersionOf"/>
        <ObjectProperty abbreviatedIRI="terms:relation"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty abbreviatedIRI="terms:references"/>
        <ObjectProperty abbreviatedIRI="terms:relation"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#addressesStudy"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#examinedBy"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasClinicalProblem"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasDisease"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasExperiment"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasExperimentKit"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasHypothesis"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasInvestigation"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasProtein"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasStudyDesign"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#hasTreatment"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#has_Treatment"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#investigate"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#investigatesProblem"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#isClinicalTrial"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#performsExperiment"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#refersExperiment"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#resistantTo"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#testOn"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useAssay"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useCellLine"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useDrug"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useGene"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useProbe"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useReagent"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useSpecimen"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SubObjectPropertyOf>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
        <ObjectProperty abbreviatedIRI="owl:topObjectProperty"/>
    </SubObjectPropertyOf>
    <SymmetricObjectProperty>
        <ObjectProperty IRI="#isClinicalTrial"/>
    </SymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#addressesStudy"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#examinedBy"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasClinicalProblem"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasDisease"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasExperiment"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasExperimentKit"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasExperimentMethod"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasHypothesis"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasInvestigation"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasProtein"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasStudyDesign"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#hasTreatment"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#has_Treatment"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#investigate"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#investigatesProblem"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#obtainedfrom"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#obtainedfromPatient"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#performsExperiment"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#refersExperiment"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#resistantTo"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#testOn"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useAssay"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useCellLine"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useDrug"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useGene"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useProbe"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useReagent"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useSpecimen"/>
    </AsymmetricObjectProperty>
    <AsymmetricObjectProperty>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
    </AsymmetricObjectProperty>
    <ReflexiveObjectProperty>
        <ObjectProperty IRI="#examinedBy"/>
    </ReflexiveObjectProperty>
    <ReflexiveObjectProperty>
        <ObjectProperty IRI="#investigate"/>
    </ReflexiveObjectProperty>
    <ReflexiveObjectProperty>
        <ObjectProperty IRI="#isClinicalTrial"/>
    </ReflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#addressesStudy"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasClinicalProblem"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasDisease"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasExperiment"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasExperimentKit"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasExperimentMethod"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasHypothesis"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasInvestigation"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasProtein"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasStudyDesign"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#hasTreatment"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#has_Treatment"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#investigatesProblem"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#obtainedfrom"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#obtainedfromPatient"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#performsExperiment"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#refersExperiment"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#resistantTo"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#testOn"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useAssay"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useCellLine"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useDrug"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useGene"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useProbe"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useReagent"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useSpecimen"/>
    </IrreflexiveObjectProperty>
    <IrreflexiveObjectProperty>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
    </IrreflexiveObjectProperty>
    <ObjectPropertyDomain>
        <ObjectProperty abbreviatedIRI="terms:creator"/>
        <Class abbreviatedIRI="bibo:Article"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty abbreviatedIRI="terms:publisher"/>
        <Class abbreviatedIRI="terms1:Publication"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty abbreviatedIRI="terms:title"/>
        <ObjectUnionOf>
            <Class abbreviatedIRI="terms1:Publication"/>
            <Class abbreviatedIRI="bibo:Article"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#addressesStudy"/>
        <Class abbreviatedIRI="terms1:Publication"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#examinedBy"/>
        <ObjectUnionOf>
            <Class IRI="#Hypothesis"/>
            <Class IRI="#levels_of_mdr1_mRNA"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasClinicalProblem"/>
        <Class IRI="#Treatment"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasDisease"/>
        <Class IRI="#Patient"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasExperiment"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasExperimentKit"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasHypothesis"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasInvestigation"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasProtein"/>
        <Class IRI="#Cell"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasStudyDesign"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#hasTreatment"/>
        <ObjectUnionOf>
            <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#has_Treatment"/>
        <Class IRI="#Disease"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#investigate"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#investigatesProblem"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#isClinicalTrial"/>
        <Class IRI="#Patient"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#obtainedfrom"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentKit"/>
            <Class IRI="#ExperimentMaterial"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <Class IRI="#Specimen"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#performsExperiment"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#refersExperiment"/>
        <Class IRI="#Investigation"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#resistantTo"/>
        <Class IRI="#Cell"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#testOn"/>
        <Class IRI="#Drug"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useAssay"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useCellLine"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentMaterial"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useDrug"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentMaterial"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
            <Class IRI="#Treatment"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useGene"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentMaterial"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useProbe"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentMaterial"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useReagent"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useSpecimen"/>
        <ObjectUnionOf>
            <Class IRI="#ExperimentMaterial"/>
            <Class IRI="#Treatment"/>
        </ObjectUnionOf>
    </ObjectPropertyDomain>
    <ObjectPropertyDomain>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyDomain>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#addressesStudy"/>
        <Class IRI="#ClinicalStudy"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#examinedBy"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasBlotAnalysis"/>
        <Class IRI="#BlotAnalysis"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasClinicalProblem"/>
        <Class IRI="#ClinicalProblem"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasDisease"/>
        <Class IRI="#Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasExperiment"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasExperimentKit"/>
        <Class IRI="#ExperimentKit"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasExperimentMaterial"/>
        <Class IRI="#ExperimentMaterial"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasExperimentMethod"/>
        <Class IRI="#Antibody-mediated_cytolysis_experiment"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasExperimentalSetting"/>
        <Class IRI="#ExperimentSetting"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasHypothesis"/>
        <Class IRI="#levels_of_mdr1_mRNA"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasInvestigation"/>
        <Class IRI="#Investigation"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasProtein"/>
        <Class IRI="#Gene"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasStudyDesign"/>
        <Class IRI="#StudyDesign"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#hasTreatment"/>
        <Class IRI="#Treatment"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#has_Treatment"/>
        <Class IRI="#Treatment"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#investigate"/>
        <Class IRI="#Disease"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#investigatesProblem"/>
        <Class IRI="#ClinicalProblem"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#isClinicalTrial"/>
        <Class IRI="#ClinicalTrial"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#obtainedfrom"/>
        <Class abbreviatedIRI="foaf:Organization"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#obtainedfromPatient"/>
        <Class IRI="#Patient"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#performsExperiment"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#refersExperiment"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#resistantTo"/>
        <Class IRI="#Drug"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#testOn"/>
        <Class IRI="#ClinicalTrial"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useAssay"/>
        <Class IRI="#Assay"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useCellLine"/>
        <Class IRI="#CellLine"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useDrug"/>
        <Class IRI="#Drug"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useGene"/>
        <Class IRI="#Gene"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useProbe"/>
        <Class IRI="#Probe"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useReagent"/>
        <Class IRI="#Reagent"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useSpecimen"/>
        <Class IRI="#Specimen"/>
    </ObjectPropertyRange>
    <ObjectPropertyRange>
        <ObjectProperty IRI="#useStatisticalAnalysis"/>
        <Class IRI="#StatisticalAnalysis"/>
    </ObjectPropertyRange>
    <SubDataPropertyOf>
        <DataProperty abbreviatedIRI="terms:abstract"/>
        <DataProperty abbreviatedIRI="terms:description"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty abbreviatedIRI="terms:bibliographicCitation"/>
        <DataProperty abbreviatedIRI="terms:identifier"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#assayTitle"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#failureReason"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasAssayMethod"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasDrugEffects"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasEligibilityCriteria"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasEvidence"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasExperimentalResult"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasFindings"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasLimitations"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasMutationResult"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasOverexpressionGene"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasProblemSolution"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasSuggestion"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasTargetingMethod"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasTissueLocalization"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#hasTitle"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#name"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <SubDataPropertyOf>
        <DataProperty IRI="#treatmentOutcome"/>
        <DataProperty abbreviatedIRI="owl:topDataProperty"/>
    </SubDataPropertyOf>
    <DataPropertyDomain>
        <DataProperty abbreviatedIRI="terms1:name"/>
        <ObjectUnionOf>
            <Class abbreviatedIRI="terms1:Contributor"/>
            <Class abbreviatedIRI="terms1:Publisher"/>
            <Class IRI="#ClinicalStudy"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty abbreviatedIRI="bibo:abstract"/>
        <ObjectUnionOf>
            <Class abbreviatedIRI="bibo:Article"/>
            <Class abbreviatedIRI="rdfs:Resource"/>
        </ObjectUnionOf>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#assayTitle"/>
        <Class IRI="#Assay"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#failureReason"/>
        <Class IRI="#Treatment"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasAssayMethod"/>
        <Class IRI="#Assay"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasDrugEffects"/>
        <Class IRI="#Drug"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasEligibilityCriteria"/>
        <ObjectUnionOf>
            <Class IRI="#ClinicalTrial"/>
            <Class IRI="#Patient"/>
        </ObjectUnionOf>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasEvidence"/>
        <Class IRI="#ClinicalStudy"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasExperimentalResult"/>
        <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasFindings"/>
        <Class IRI="#ClinicalStudy"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasLimitations"/>
        <Class IRI="#ClinicalStudy"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasMutationResult"/>
        <Class IRI="#ClinicalProblem"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasOverexpressionGene"/>
        <Class IRI="#ClinicalProblem"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasProblemSolution"/>
        <Class IRI="#ClinicalProblem"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasSuggestion"/>
        <Class IRI="#ClinicalStudy"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasTargetingMethod"/>
        <Class IRI="#ClinicalProblem"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasTissueLocalization"/>
        <Class IRI="#ClinicalProblem"/>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#hasTitle"/>
        <ObjectUnionOf>
            <Class IRI="#ClinicalStudy"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#name"/>
        <ObjectUnionOf>
            <Class IRI="#Disease"/>
            <Class IRI="#Drug"/>
            <Class IRI="#Multidrug_resistance_to_cancer_cells"/>
        </ObjectUnionOf>
    </DataPropertyDomain>
    <DataPropertyDomain>
        <DataProperty IRI="#treatmentOutcome"/>
        <Class IRI="#Treatment"/>
    </DataPropertyDomain>
    <DataPropertyRange>
        <DataProperty IRI="#assayTitle"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#failureReason"/>
        <Datatype abbreviatedIRI="xsd:string"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasAssayMethod"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasDrugEffects"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasEligibilityCriteria"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasEvidence"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasExperimentalResult"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasFindings"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasLimitations"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasMutationResult"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasOverexpressionGene"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasProblemSolution"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasSuggestion"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasTargetingMethod"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasTissueLocalization"/>
        <Datatype abbreviatedIRI="xsd:string"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#hasTitle"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#name"/>
        <Datatype abbreviatedIRI="xsd:string"/>
    </DataPropertyRange>
    <DataPropertyRange>
        <DataProperty IRI="#treatmentOutcome"/>
        <Datatype abbreviatedIRI="rdfs:Literal"/>
    </DataPropertyRange>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>terms1:Publication</AbbreviatedIRI>
        <Literal xml:lang="en">The :Publication class groups together all individuals (or part of) created as the result of the publishing process. Note that we are not referring here to the physical artefacts, but just their abstract counterparts.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>terms1:Publisher</AbbreviatedIRI>
        <Literal xml:lang="en">The :Publisher class represents organizations involved in the publishing business.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2012-06-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
        <IRI>http://purl.org/dc/aboutdcmi#DCMI</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
        <Literal xml:lang="en">DCMI Metadata Terms - other</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <Literal xml:lang="en">Examples of Agent Class include groups seen as classes, such as students, women, charities, lecturers.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#AgentClass-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2012-06-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <Literal xml:lang="en">A group of agents.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:AgentClass</AbbreviatedIRI>
        <Literal xml:lang="en">Agent Class</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#BibliographicResource-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
        <Literal xml:lang="en">A book, article, or other documentary resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
        <Literal xml:lang="en">Bibliographic Resource</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Box-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <Literal xml:lang="en">The set of regions in space defined by their geographic coordinates according to the DCMI Box Encoding Scheme.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <Literal xml:lang="en">DCMI Box</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:Box</AbbreviatedIRI>
        <IRI>http://dublincore.org/documents/dcmi-box/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#DCMIType-005</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2012-06-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <Literal xml:lang="en">The set of classes specified by the DCMI Type Vocabulary, used to categorize the nature or genre of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <Literal xml:lang="en">DCMI Type Vocabulary</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:DCMIType</AbbreviatedIRI>
        <IRI>http://purl.org/dc/dcmitype/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#DDC-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <Literal xml:lang="en">The set of conceptual resources specified by the Dewey Decimal Classification.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <Literal xml:lang="en">DDC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:DDC</AbbreviatedIRI>
        <IRI>http://www.oclc.org/dewey/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Frequency</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Frequency-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Frequency</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Frequency</AbbreviatedIRI>
        <Literal xml:lang="en">A rate at which something recurs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Frequency</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Frequency</AbbreviatedIRI>
        <Literal xml:lang="en">Frequency</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#IMT-004</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <Literal xml:lang="en">The set of media types specified by the Internet Assigned Numbers Authority.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <Literal xml:lang="en">IMT</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:IMT</AbbreviatedIRI>
        <IRI>http://www.iana.org/assignments/media-types/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#ISO3166-004</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <Literal xml:lang="en">The set of codes listed in ISO 3166-1 for the representation of names of countries.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <Literal xml:lang="en">ISO 3166</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:ISO3166</AbbreviatedIRI>
        <IRI>http://www.iso.org/iso/en/prods-services/iso3166ma/02iso-3166-code-lists/list-en1.html</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#ISO639-2-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <Literal xml:lang="en">The three-letter alphabetic codes listed in ISO639-2 for the representation of names of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <Literal xml:lang="en">ISO 639-2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:ISO639-2</AbbreviatedIRI>
        <IRI>http://lcweb.loc.gov/standards/iso639-2/langhome.html</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#ISO639-3-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <Literal xml:lang="en">The set of three-letter codes listed in ISO 639-3 for the representation of names of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <Literal xml:lang="en">ISO 639-3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:ISO639-3</AbbreviatedIRI>
        <IRI>http://www.sil.org/iso639-3/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#LCC-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <Literal xml:lang="en">The set of conceptual resources specified by the Library of Congress Classification.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <Literal xml:lang="en">LCC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:LCC</AbbreviatedIRI>
        <IRI>http://lcweb.loc.gov/catdir/cpso/lcco/lcco.html</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#LCSH-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <Literal xml:lang="en">The set of labeled concepts specified by the Library of Congress Subject Headings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:LCSH</AbbreviatedIRI>
        <Literal xml:lang="en">LCSH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#LicenseDocument-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
        <Literal xml:lang="en">A legal document giving official permission to do something with a Resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
        <Literal xml:lang="en">License Document</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <Literal xml:lang="en">Examples include written, spoken, sign, and computer languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#LinguisticSystem-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <Literal xml:lang="en">A system of signs, symbols, sounds, gestures, or rules used in communication.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
        <Literal xml:lang="en">Linguistic System</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#MESH-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <Literal xml:lang="en">The set of labeled concepts specified by the Medical Subject Headings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <Literal xml:lang="en">MeSH</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:MESH</AbbreviatedIRI>
        <IRI>http://www.nlm.nih.gov/mesh/meshhome.html</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:MethodOfAccrual</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#MethodOfAccrual-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:MethodOfAccrual</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:MethodOfAccrual</AbbreviatedIRI>
        <Literal xml:lang="en">A method by which resources are added to a collection.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:MethodOfAccrual</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:MethodOfAccrual</AbbreviatedIRI>
        <Literal xml:lang="en">Method of Accrual</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:MethodOfInstruction</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#MethodOfInstruction-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:MethodOfInstruction</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:MethodOfInstruction</AbbreviatedIRI>
        <Literal xml:lang="en">A process that is used to engender knowledge, attitudes, and skills.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:MethodOfInstruction</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:MethodOfInstruction</AbbreviatedIRI>
        <Literal xml:lang="en">Method of Instruction</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#NLM-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2005-06-13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <Literal xml:lang="en">The set of conceptual resources specified by the National Library of Medicine Classification.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <Literal xml:lang="en">NLM</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:NLM</AbbreviatedIRI>
        <IRI>http://wwwcf.nlm.nih.gov/class/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Period-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <Literal xml:lang="en">The set of time intervals defined by their limits according to the DCMI Period Encoding Scheme.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <Literal xml:lang="en">DCMI Period</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:Period</AbbreviatedIRI>
        <IRI>http://dublincore.org/documents/dcmi-period/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:PhysicalResource</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#PhysicalResource-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:PhysicalResource</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:PhysicalResource</AbbreviatedIRI>
        <Literal xml:lang="en">A material thing.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:PhysicalResource</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:PhysicalResource</AbbreviatedIRI>
        <Literal xml:lang="en">Physical Resource</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Point-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <Literal xml:lang="en">The set of points in space defined by their geographic coordinates according to the DCMI Point Encoding Scheme.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <Literal xml:lang="en">DCMI Point</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:Point</AbbreviatedIRI>
        <IRI>http://dublincore.org/documents/dcmi-point/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Policy</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Policy-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Policy</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Policy</AbbreviatedIRI>
        <Literal xml:lang="en">A plan or course of action by an authority, intended to influence and determine decisions, actions, and other matters.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Policy</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Policy</AbbreviatedIRI>
        <Literal xml:lang="en">Policy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:ProvenanceStatement</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#ProvenanceStatement-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:ProvenanceStatement</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:ProvenanceStatement</AbbreviatedIRI>
        <Literal xml:lang="en">A statement of any changes in ownership and custody of a resource since its creation that are significant for its authenticity, integrity, and interpretation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:ProvenanceStatement</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:ProvenanceStatement</AbbreviatedIRI>
        <Literal xml:lang="en">Provenance Statement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#RFC1766-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <Literal xml:lang="en">The set of tags, constructed according to RFC 1766, for the identification of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 1766</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:RFC1766</AbbreviatedIRI>
        <IRI>http://www.ietf.org/rfc/rfc1766.txt</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 3066 has been obsoleted by RFC 4646.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#RFC3066-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2002-07-13</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <Literal xml:lang="en">The set of tags constructed according to RFC 3066 for the identification of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 3066</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:RFC3066</AbbreviatedIRI>
        <IRI>http://www.ietf.org/rfc/rfc3066.txt</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 4646 obsoletes RFC 3066.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#RFC4646-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <Literal xml:lang="en">The set of tags constructed according to RFC 4646 for the identification of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 4646</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:RFC4646</AbbreviatedIRI>
        <IRI>http://www.ietf.org/rfc/rfc4646.txt</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 5646 obsoletes RFC 4646.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#RFC5646-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <Literal xml:lang="en">The set of tags constructed according to RFC 5646 for the identification of languages.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <Literal xml:lang="en">RFC 5646</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:RFC5646</AbbreviatedIRI>
        <IRI>http://www.ietf.org/rfc/rfc5646.txt</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#RightsStatement-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
        <Literal xml:lang="en">A statement about the intellectual property rights (IPR) held in or over a Resource, a legal document giving official permission to do something with a resource, or a statement about access rights.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
        <Literal xml:lang="en">Rights Statement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#Standard-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
        <Literal xml:lang="en">A basis for comparison; a reference point against which other things can be evaluated.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
        <Literal xml:lang="en">Standard</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#TGN-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <Literal xml:lang="en">The set of places specified by the Getty Thesaurus of Geographic Names.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <Literal xml:lang="en">TGN</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:TGN</AbbreviatedIRI>
        <IRI>http://www.getty.edu/research/tools/vocabulary/tgn/index.html</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#UDC-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <Literal xml:lang="en">The set of conceptual resources specified by the Universal Decimal Classification.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <Literal xml:lang="en">UDC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:UDC</AbbreviatedIRI>
        <IRI>http://www.udcc.org/</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#URI-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <Literal xml:lang="en">The set of identifiers constructed according to the generic syntax for Uniform Resource Identifiers as specified by the Internet Engineering Task Force.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <Literal xml:lang="en">URI</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:URI</AbbreviatedIRI>
        <IRI>http://www.ietf.org/rfc/rfc3986.txt</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#W3CDTF-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <Literal xml:lang="en">The set of dates and times constructed according to the W3C Date and Time Formats Specification.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <Literal xml:lang="en">W3C-DTF</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:seeAlso"/>
        <AbbreviatedIRI>terms:W3CDTF</AbbreviatedIRI>
        <IRI>http://www.w3.org/TR/NOTE-datetime</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#abstract-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <Literal xml:lang="en">A summary of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:abstract</AbbreviatedIRI>
        <Literal xml:lang="en">Abstract</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal xml:lang="en">An alternative name for the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal xml:lang="en">The distinction between titles and alternative titles is application-specific.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#alternative-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal xml:lang="en">An alternative name for the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:alternative</AbbreviatedIRI>
        <Literal xml:lang="en">Alternative Title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <Literal xml:lang="en">Recommended practice is to include sufficient bibliographic detail to identify the resource as unambiguously as possible.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#bibliographicCitation-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2003-02-15</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <Literal xml:lang="en">A bibliographic reference for the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:bibliographicCitation</AbbreviatedIRI>
        <Literal xml:lang="en">Bibliographic Citation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <Literal xml:lang="en">Examples of a Contributor include a person, an organization, or a service.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#contributorT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <Literal xml:lang="en">An entity responsible for making contributions to the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:contributor</AbbreviatedIRI>
        <Literal xml:lang="en">Contributor</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <Literal xml:lang="en">Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN]. Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#coverageT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <Literal xml:lang="en">The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:coverage</AbbreviatedIRI>
        <Literal xml:lang="en">Coverage</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <Literal xml:lang="en">Examples of a Creator include a person, an organization, or a service.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#creatorT-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <Literal xml:lang="en">An entity primarily responsible for making the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:creator</AbbreviatedIRI>
        <Literal xml:lang="en">Creator</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <Literal xml:lang="en">Description may include but is not limited to: an abstract, a table of contents, a graphical representation, or a free-text account of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#descriptionT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <Literal xml:lang="en">An account of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:description</AbbreviatedIRI>
        <Literal xml:lang="en">Description</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#hasPart-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource that is included either physically or logically in the described resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <Literal xml:lang="en">Has Part</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:hasPart</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <Literal xml:lang="en">Recommended best practice is to identify the resource by means of a string conforming to a formal identification system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#identifierT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <Literal xml:lang="en">An unambiguous reference to the resource within a given context.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:identifier</AbbreviatedIRI>
        <Literal xml:lang="en">Identifier</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#isPartOf-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource in which the described resource is physically or logically included.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <Literal xml:lang="en">Is Part Of</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:isPartOf</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#isReferencedBy-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource that references, cites, or otherwise points to the described resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <Literal xml:lang="en">Is Referenced By</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:isReferencedBy</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal xml:lang="en">Changes in version imply substantive changes in content rather than differences in format.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#isVersionOf-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource of which the described resource is a version, edition, or adaptation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal xml:lang="en">Is Version Of</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:isVersionOf</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <Literal xml:lang="en">Recommended best practice is to use a controlled vocabulary such as RFC 4646 [RFC4646].</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#languageT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <Literal xml:lang="en">A language of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:language</AbbreviatedIRI>
        <Literal xml:lang="en">Language</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal xml:lang="en">An entity responsible for making the resource available.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal xml:lang="en">Examples of a Publisher include a person, an organization, or a service.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#publisherT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal xml:lang="en">An entity responsible for making the resource available.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:publisher</AbbreviatedIRI>
        <Literal xml:lang="en">Publisher</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#references-003</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2000-07-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource that is referenced, cited, or otherwise pointed to by the described resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <Literal xml:lang="en">References</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:references</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal xml:lang="en">Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#relationT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal xml:lang="en">A related resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal xml:lang="en">Relation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:relation</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal xml:lang="en">Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#subjectT-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2012-06-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal xml:lang="en">The topic of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal xml:lang="en">Subject</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:note"/>
        <AbbreviatedIRI>terms:subject</AbbreviatedIRI>
        <Literal xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <Literal xml:lang="en">A name given to the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#titleT-002</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2010-10-11</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <Literal xml:lang="en">A name given to the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:title</AbbreviatedIRI>
        <Literal xml:lang="en">Title</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <Literal xml:lang="en">Recommended best practice is to use a controlled vocabulary such as the DCMI Type Vocabulary [DCMITYPE]. To describe the file format, physical medium, or dimensions of the resource, use the Format element.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <IRI>http://dublincore.org/usage/terms/history/#typeT-001</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <Literal datatypeIRI="http://www.w3.org/2001/XMLSchema#date">2008-01-14</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <Literal xml:lang="en">The nature or genre of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:isDefinedBy"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <AbbreviatedIRI>terms:</AbbreviatedIRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <AbbreviatedIRI>terms:type</AbbreviatedIRI>
        <Literal xml:lang="en">Type</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <AbbreviatedIRI>bibo:abstract</AbbreviatedIRI>
        <Literal xml:lang="en">A summary of the resource.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#A._T._FoJo</IRI>
        <Literal>A. T. Fojo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ABCA2</IRI>
        <Literal xml:lang="en">ABCA2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ABC_genes</IRI>
        <Literal xml:lang="en">ABC_genes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ABC_transporters_and_in_vitro_MDR</IRI>
        <Literal xml:lang="en">ABC_transporters_and_in_vitro_MDR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal</IRI>
        <IRI>#Cheol-Hee_Choi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal</IRI>
        <IRI>#Cancer_Cell_International</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">ABC transporters as multidrug resistance mechanisms and the
development of chemosensitizers for their reversal</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ABC_transporters_in_human_cancers</IRI>
        <Literal xml:lang="en">ABC transporters in human cancers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ADE</IRI>
        <Literal xml:lang="en">ADE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ALL</IRI>
        <Literal xml:lang="en">ALL</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#AML</IRI>
        <Literal xml:lang="en">AML</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#AML_sample</IRI>
        <Literal xml:lang="en">AML_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ARUN_K._RISHI</IRI>
        <Literal>Arun k. Rishi</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#ARUN_K._RISHI</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#DOUGLAS_D._ROSS</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#L._AUSTIN_DOYLE</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#LYNNE_V._ABRUZZO</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#TAMMY_KROGMANN</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#WEIDONG_YANG</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#YONGMING_GAO</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <IRI>#Proc._Nati._Acad._Sci._USA</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">A multidrug resistance transporter from human MCF-7 breast cancer cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Accumulation_Bioassay</IRI>
        <Literal xml:lang="en">Accumulation_Bioassay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Actinomycin_D</IRI>
        <Literal xml:lang="en">Actinomycin_D</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Acute_lymphoblastic_leukemia</IRI>
        <Literal xml:lang="en">Acute_lymphoblastic_leukemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Adrenocortical_Cancer</IRI>
        <Literal xml:lang="en">Adrenocortical_Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Advanced_and_recurrent_breast_cancer_sample</IRI>
        <Literal xml:lang="en">Advanced_and_recurrent_breast_cancer_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Analysis_of_leukemic_blast_MDR_function</IRI>
        <Literal xml:lang="en">Analysis_of_leukemic_blast_MDR_function</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Anthracyclines-doxorubucin_daunorubicin_epirubicin</IRI>
        <Literal xml:lang="en">Anthracyclines-doxorubucin_daunorubicin_epirubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Anthranilic-acid-based_drug</IRI>
        <Literal xml:lang="en">Anthranilic-acid-based_drug</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Antibody-mediated_cytolysis_experiment</IRI>
        <Literal xml:lang="en">An experimental method is a way to solve a scientific task by executing a scientific experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Antibody-mediated_cytolysis_experiment</IRI>
        <Literal xml:lang="en">ExperimentMethod</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Assay</IRI>
        <Literal xml:lang="en">A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Assay</IRI>
        <Literal xml:lang="en">Assay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#AssayKit</IRI>
        <Literal xml:lang="en">The title of the kit/biologicals used in the assay.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#AssayKit</IRI>
        <Literal xml:lang="en">AssayKit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#AssayMethod</IRI>
        <Literal xml:lang="en">The methods required to perform typical screening assay. Assay methods include laboratory methods.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#AssayMethod</IRI>
        <Literal xml:lang="en">AssayMethod</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Asuka_Mizutani</IRI>
        <Literal>Asuka Mizutani</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BBR3390</IRI>
        <Literal xml:lang="en">BBR3390</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BCRP</IRI>
        <Literal xml:lang="en">BCRP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BH3_profiling</IRI>
        <Literal xml:lang="en">BH3_profiling</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BH3_profiling_method</IRI>
        <Literal xml:lang="en">BH3_profiling_method</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Bevacizumab</IRI>
        <Literal xml:lang="en">Bevacizumab</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Blast_populations_in_the_two_bioassays</IRI>
        <Literal xml:lang="en">Blast populations in the two bioassays</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Blast_populations_in_the_two_bioassays</IRI>
        <Literal xml:lang="en">P-gp accumulation ratio, P-gp efflux ratio, percent unimpeded efflux for total MDR activity, percent efflux in the presence of zosuquidar, and percent inhibition of efflux by zosuquidar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#BlotAnalysis</IRI>
        <Literal xml:lang="en">The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BlotAnalysis</IRI>
        <Literal xml:lang="en">BlotAnalysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Bone_marrow_aspirates</IRI>
        <Literal xml:lang="en">Bone_marrow_aspirates</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Bortezomib</IRI>
        <Literal xml:lang="en">Bortezomib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Branimir_I._Sikic</IRI>
        <Literal>Branimir I. Sikic</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Breast_Cancer</IRI>
        <Literal xml:lang="en">Breast_Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Breast_cancer_samples</IRI>
        <Literal xml:lang="en">Breast_cancer_samples</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CAVE</IRI>
        <Literal xml:lang="en">CAVE</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CCL_127__PC12</IRI>
        <Literal xml:lang="en">CCL_127__PC12</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CI1033</IRI>
        <Literal xml:lang="en">CI1033</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CML</IRI>
        <Literal xml:lang="en">CML</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Caitriona_Holohan</IRI>
        <Literal>Caitriona Holohan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cancer_chemotherapy_doxorubicin_vinblastine</IRI>
        <Literal xml:lang="en">Cancer_chemotherapy_doxorubicin_vinblastine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <IRI>#Caitriona_Holohan</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <IRI>#Daniel_B._Longley</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <IRI>#Patrick_G._Johnston</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <IRI>#Sandra_Van_Schaeybroeck</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <IRI>#Macmillan_Magazines_Ltd</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Cancer_drug_resistance_an_evolving_paradigm</IRI>
        <Literal xml:lang="en">Cancer drug resistance: an evolving paradigm</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Carboplatin</IRI>
        <Literal xml:lang="en">Carboplatin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Catherine_Booth-Genthe</IRI>
        <Literal>Catherine Booth Genthe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Cell</IRI>
        <Literal xml:lang="en">A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cell</IRI>
        <Literal xml:lang="en">Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CellLine</IRI>
        <Literal xml:lang="en">CellLine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#CellLine</IRI>
        <Literal xml:lang="en">The term &apos;line&apos; is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cetuximab</IRI>
        <Literal xml:lang="en">Cetuximab</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chemical</IRI>
        <Literal xml:lang="en">Chemical</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Chemical</IRI>
        <Literal xml:lang="en">A substance composed of chemical elements.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chemotherapy</IRI>
        <Literal xml:lang="en">Chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport</IRI>
        <Literal xml:lang="en">Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cheol-Hee_Choi</IRI>
        <Literal>Cheol Hee Choi</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ClinicalProblem</IRI>
        <Literal xml:lang="en">A difficulty, disorder, or condition needing resolution.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ClinicalProblem</IRI>
        <Literal xml:lang="en">ClinicalProblem</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ClinicalStudy</IRI>
        <Literal xml:lang="en">A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ClinicalStudy</IRI>
        <Literal xml:lang="en">ClinicalStudy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ClinicalTrial</IRI>
        <Literal xml:lang="en">Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ClinicalTrial</IRI>
        <Literal xml:lang="en">ClinicalTrial</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Clonogenic_survival_assays</IRI>
        <Literal xml:lang="en">Clonogenic_survival_assays</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Colchicine</IRI>
        <Literal xml:lang="en">Colchicine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Colerectal_cancer</IRI>
        <Literal xml:lang="en">Colerectal_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Colon_Tumor</IRI>
        <Literal xml:lang="en">Colerectal_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Colon_carcinoma</IRI>
        <Literal xml:lang="en">Colon_carcinoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Crizotinib</IRI>
        <Literal xml:lang="en">Crizotinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cyclosporine</IRI>
        <Literal xml:lang="en">Cyclosporine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Cytarabine</IRI>
        <Literal xml:lang="en">Cytarabine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#D._G._POPLACK</IRI>
        <Literal>D. G. Poplack</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#D._J._SLAMON</IRI>
        <Literal>D. J. Slamon</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#DOUGLAS_D._ROSS</IRI>
        <Literal>Douglas D. Ross</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Daniel_B._Longley</IRI>
        <Literal>Daniel B. Longley</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Dasatinib</IRI>
        <Literal xml:lang="en">Dasatinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Daunomycin</IRI>
        <Literal xml:lang="en">Daunomycin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Daunorubicin</IRI>
        <Literal xml:lang="en">Daunorubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Delta_RNA_Fingerprinting_kit</IRI>
        <Literal xml:lang="en">Delta_RNA_Fingerprinting_kit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>#Describe_various_approaches_to_combating_multidrug-resistant_cancer</IRI>
        <Literal>The most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Describe_various_approaches_to_combating_multidrug-resistant_cancer</IRI>
        <Literal xml:lang="en">Describe_various_approaches_to_combating_multidrug-resistant_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#DiOC2</IRI>
        <Literal xml:lang="en">DiOC2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Asuka_Mizutani</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Ikumi_Tamai</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Kazuki_Fukuchi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Keiichi_Kawai</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Kodai_Nishi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Masato_Kobayashi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Ryuichi_Nishii</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Takafumi_Tsujiuchi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Takeo_Nakanishi</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Yuya_Okui</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <IRI>#Springer_Science+Business_Media_LLC</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <Literal xml:lang="en">Different Efflux Transporter Aff inity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators</IRI>
        <Literal xml:lang="en">Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Disease</IRI>
        <Literal xml:lang="en">A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Disease</IRI>
        <Literal xml:lang="en">Disease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Doxorubicin</IRI>
        <Literal xml:lang="en">Doxorubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drosophila_white_gene</IRI>
        <Literal xml:lang="en">Drosophila_white_gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drug</IRI>
        <Literal xml:lang="en">Drug</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Drug</IRI>
        <Literal xml:lang="en">Therapeutic agent; any substance, other than food, used in the prevention, diagnosis, alleviation, treatment, or cure of disease. For types or classifications of drugs, see the specific name.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drug_Resistance</IRI>
        <Literal xml:lang="en">Drug_Resistance</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters</IRI>
        <Literal xml:lang="en">Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>#Drug_resistance_and_its_role_in_clinical_oncology</IRI>
        <Literal>Cellular mechanisms of multidrug resistance and ATP-binding cassette (ABC) transporters</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Drug_resistance_and_its_role_in_clinical_oncology</IRI>
        <Literal xml:lang="en">Drug_resistance_and_its_role_in_clinical_oncology</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#EasternBlotting</IRI>
        <Literal xml:lang="en">The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <IRI>#EasternBlotting</IRI>
        <Literal xml:lang="en">The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#EasternBlotting</IRI>
        <Literal xml:lang="en">EasternBlotting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Eastern_Blot_Analysis</IRI>
        <Literal xml:lang="en">Eastern_Blot_Analysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Efflux_Bioassay</IRI>
        <Literal xml:lang="en">Efflux_Bioassay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Elisabeth_Paietta</IRI>
        <Literal>Elisabeth Paietta</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Endogenous_and_exogenous_substrates_for_ABC_transporters</IRI>
        <Literal xml:lang="en">Endogenous_and_exogenous_substrates_for_ABC_transporters</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Epirubicin</IRI>
        <Literal xml:lang="en">Epirubicin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Etoposide</IRI>
        <Literal xml:lang="en">Etoposide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:title"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <Literal xml:lang="en">Evidence of a Role for Functional Heterogeneity in
Multidrug Resistance Transporters in Clinical Trials of
P-Glycoprotein Modulation in Acute Myeloid Leukemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <IRI>#Branimir_I._Sikic</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <IRI>#Elisabeth_Paietta</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <IRI>#John_F._Marcelletti</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <IRI>#Larry_D._Cripe</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia</IRI>
        <IRI>#International_Clinical_Cytometry_Society</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ExperimentKit</IRI>
        <Literal xml:lang="en">The title of the kit/biologicals used in the experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ExperimentKit</IRI>
        <Literal xml:lang="en">ExperimentKit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ExperimentMaterial</IRI>
        <Literal xml:lang="en">Materials are culture collections and chemicals used for executing of an experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ExperimentMaterial</IRI>
        <Literal xml:lang="en">ExperimentMaterial</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ExperimentSetting</IRI>
        <Literal xml:lang="en">A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ExperimentSetting</IRI>
        <Literal xml:lang="en">ExperimentSetting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ExperimentalStudy</IRI>
        <Literal xml:lang="en">Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ExperimentalStudy</IRI>
        <Literal xml:lang="en">ExperimentalStudy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Experimental_Study</IRI>
        <Literal xml:lang="en">Experimental Study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene</IRI>
        <Literal xml:lang="en">Expression_of_a_multidrug-resistance_gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#D._G._POPLACK</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#D._J._SLAMON</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#I._PASTAN</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#K._UEDA</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#M._M._GOTTESMAN</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <IRI>#Proc._Nati._Acad._Sci._USA</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Expression of a multidrug-resistance gene in human tumors and tissues</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Flavopiridol</IRI>
        <Literal xml:lang="en">Flavopiridol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Fluorochrome-labeled_anti-CD_antibodies</IRI>
        <Literal xml:lang="en">Fluorochrome-labeled_anti-CD_antibodies</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Fluorouracil</IRI>
        <Literal xml:lang="en">Fluorouracil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Functional_Assay</IRI>
        <Literal xml:lang="en">Functional_Assay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Functional_Bioassay</IRI>
        <Literal xml:lang="en">Functional_Bioassay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Functions_of_ABC_transporters_in_Chemotherapy</IRI>
        <Literal xml:lang="en">Functions_of_ABC_transporters_in_Chemotherapy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gastrointestinal_stromal_tumour_GIST_cell_lines</IRI>
        <Literal xml:lang="en">Gastrointestinal_stromal_tumour_GIST_cell_lines</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gefitinib</IRI>
        <Literal xml:lang="en">Gefitinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">Gene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Gene</IRI>
        <Literal xml:lang="en">One of the biologic units of heredity, self-reproducing, and located at a definite position (locus) on a particular chromosome.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Growth_inhibition_assays</IRI>
        <Literal xml:lang="en">Growth_inhibition_assays</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#HTB_10_HTB_11_HTB_38</IRI>
        <Literal xml:lang="en">HTB_10_HTB_11_HTB_38</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Head_and_neck_cancer</IRI>
        <Literal xml:lang="en">Head_and_neck_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#High-risk_MDS_sample</IRI>
        <Literal xml:lang="en">High-risk_MDS_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Hypothesis</IRI>
        <Literal xml:lang="en">A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Hypothesis</IRI>
        <Literal xml:lang="en">Hypothesis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#IL-2</IRI>
        <Literal xml:lang="en">IL-2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Iamivudine</IRI>
        <Literal xml:lang="en">Iamivudine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Idarubicine</IRI>
        <Literal xml:lang="en">Idarubicine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Idarubicinol</IRI>
        <Literal xml:lang="en">Idarubicinol</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP</IRI>
        <Literal xml:lang="en">Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Ifosfamide</IRI>
        <Literal xml:lang="en">Ifosfamide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Imatinib</IRI>
        <Literal xml:lang="en">Imatinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Immunosuppressant_cyclosporin_A</IRI>
        <Literal xml:lang="en">Immunosuppressant_cyclosporin_A</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Indolocarbazole</IRI>
        <Literal xml:lang="en">Indolocarbazole</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Investigation</IRI>
        <Literal xml:lang="en">Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Investigation</IRI>
        <Literal xml:lang="en">Investigation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#KB-3-1_KB-8-5_KB-V1</IRI>
        <Literal xml:lang="en">KB-3-1_KB-8-5_KB-V1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Leukaemia</IRI>
        <Literal xml:lang="en">Leukaemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Leukotriene_C4</IRI>
        <Literal xml:lang="en">Leukotriene_C4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>#Levels_of_mdrl_mRNA</IRI>
        <Literal>Since expression of the mdrl gene is responsible for multidrug resistance in tissue culture systems, we measured levels of mdrl mRNA in normal human tissues and in untreated and treated human cancers.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Levels_of_mdrl_mRNA</IRI>
        <Literal xml:lang="en">Levels_of_mdrl_mRNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Lung_cancer</IRI>
        <Literal xml:lang="en">Lung_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Lymphoma</IRI>
        <Literal xml:lang="en">Lymphoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MCF-7_human_breast_carcinoma_cells</IRI>
        <Literal xml:lang="en">MCF-7_human_breast_carcinoma_cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MDR2</IRI>
        <Literal xml:lang="en">MDR2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP1</IRI>
        <Literal xml:lang="en">MRP1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP2</IRI>
        <Literal xml:lang="en">MRP2</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP3</IRI>
        <Literal xml:lang="en">MRP3</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP4</IRI>
        <Literal xml:lang="en">MRP4</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP5</IRI>
        <Literal xml:lang="en">MRP5</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP6</IRI>
        <Literal xml:lang="en">MRP6</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP7</IRI>
        <Literal xml:lang="en">MRP7</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MRP8</IRI>
        <Literal xml:lang="en">MRP8</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment</IRI>
        <Literal xml:lang="en">Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Melanoma</IRI>
        <Literal xml:lang="en">Melanoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Melanoma_cell_line</IRI>
        <Literal xml:lang="en">Melanoma_cell_line</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Methotrexate</IRI>
        <Literal xml:lang="en">Methotrexate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Mitomycin_C</IRI>
        <Literal xml:lang="en">Mitomycin_C</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Mitoxantrone</IRI>
        <Literal xml:lang="en">Mitoxantrone</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Multidrug_Resistance_Monitoring_in_Cancer</IRI>
        <Literal xml:lang="en">Multidrug_Resistance_Monitoring_in_Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Multidrug_resistance-MDR_in_cancer_Mechanisms</IRI>
        <Literal xml:lang="en">Multidrug_resistance-MDR_in_cancer_Mechanisms</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells</IRI>
        <Literal xml:lang="en">Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells</IRI>
        <Literal xml:lang="en">Multidrug resistance (MDR) efflux pumps capable of
eliminating chemotherapeutic drugs from tumor cells
contribute to clinical drug resistance in acute myeloid
leukemia (AML) and other cancers.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs</IRI>
        <IRI>#Lawrence_D._Mayer</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs</IRI>
        <IRI>#Rajesh_Krishna</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs</IRI>
        <IRI>#European_Journal_of_Pharmaceutical_Sciences</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP</IRI>
        <IRI>#DOUGLAS_D._ROSS</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP</IRI>
        <IRI>#L._AUSTIN_DOYLE</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP</IRI>
        <IRI>#Nature_Publishing_Group</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Multidrug_resistance_to_cancer_cells</IRI>
        <Literal xml:lang="en">A procedure done in order to discover or demonstrate some fact or general truth.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Multidrug_resistance_to_cancer_cells</IRI>
        <Literal xml:lang="en">Experiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Multiple_chemotherapeutic_agents</IRI>
        <Literal xml:lang="en">Multiple_chemotherapeutic_agents</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Myeloma</IRI>
        <Literal xml:lang="en">Myeloma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#NSCLC</IRI>
        <Literal xml:lang="en">NSCLC</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#NSCLC_cell_lines</IRI>
        <Literal xml:lang="en">NSCLC_cell_lines</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#NSCLC_sample</IRI>
        <Literal xml:lang="en">NSCLC_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neck_squamous_cell_carcinoma_cell_lines</IRI>
        <Literal xml:lang="en">Neck_squamous_cell_carcinoma_cell_lines</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neuroblastoma</IRI>
        <Literal xml:lang="en">Neuroblastoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neuroblastoma_Cell</IRI>
        <Literal xml:lang="en">Neuroblastoma_Cell</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Neuroepithelioma</IRI>
        <Literal xml:lang="en">Neuroepithelioma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Nilotinib</IRI>
        <Literal xml:lang="en">Nilotinib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar</IRI>
        <Literal xml:lang="en">Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar</IRI>
        <Literal xml:lang="en">Non-P-gp MDR contributed to negative results with zosuquidar in AML trials
like ECOG-ACRIN E3999</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Non_Smallcell_Lung_Cancer</IRI>
        <Literal xml:lang="en">Non_Smallcell_Lung_Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#NorthernBlotting</IRI>
        <Literal xml:lang="en">A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#NorthernBlotting</IRI>
        <Literal xml:lang="en">NorthernBlotting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Northern_analysis_of_the_expression_of_BCRP_mRNA</IRI>
        <Literal xml:lang="en">Northern_analysis_of_the_expression_of_BCRP_mRNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ObservationalStudy</IRI>
        <Literal xml:lang="en">Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn&apos;t exposed to it.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ObservationalStudy</IRI>
        <Literal xml:lang="en">ObservationalStudy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Observational_Study</IRI>
        <Literal xml:lang="en">Observational Study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Ovarian_cancer</IRI>
        <Literal xml:lang="en">Ovarian_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance</IRI>
        <Literal>The focus of this review is P-GP-mediated MDR, a general overview of the underlying mechanisms and types of drug resistance is presented in the context of the overall MDR phenomenon.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance</IRI>
        <Literal xml:lang="en">P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Paclitaxel</IRI>
        <Literal xml:lang="en">Paclitaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pancreatic_cancer</IRI>
        <Literal xml:lang="en">Pancreatic_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pancreatic_cancer_cell_lines</IRI>
        <Literal xml:lang="en">Pancreatic_cancer_cell_lines</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Patient</IRI>
        <Literal xml:lang="en">A person who is under medical care or treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Patient</IRI>
        <Literal xml:lang="en">Patient</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Patient_with_adrenocortical_cancer_and_breast_cancer</IRI>
        <Literal xml:lang="en">Patient_with_adrenocortical_cancer_and_breast_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Peripheral_blood_lymphocytes</IRI>
        <Literal xml:lang="en">Peripheral_blood_lymphocytes</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Phase_III_clinical_trials_with_ABC_transporter_inhibitors</IRI>
        <Literal xml:lang="en">Phase_III_clinical_trials_with_ABC_transporter_inhibitors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Phase_II_clinical_trials_in_patients</IRI>
        <Literal xml:lang="en">Phase_II_clinical_trials_in_patients</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Pheochromocytoma</IRI>
        <Literal xml:lang="en">Pheochromocytoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Podophyllotoxin</IRI>
        <Literal xml:lang="en">Podophyllotoxin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Podophyllotoxin-etoposide_teniposide</IRI>
        <Literal xml:lang="en">Podophyllotoxin-etoposide_teniposide</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Poor-risk_acute_leukaemia_samples</IRI>
        <Literal xml:lang="en">Poor-risk_acute_leukaemia_samples</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Prazocin</IRI>
        <Literal xml:lang="en">Prazocin</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Probe</IRI>
        <Literal xml:lang="en">Probe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Probe</IRI>
        <Literal xml:lang="en">A radioactive or chemiluminescent DNA or RNA fragment used to detect the presence of a complementary fragment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#RNA_Fingerprinting</IRI>
        <Literal xml:lang="en">RNA_Fingerprinting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition</IRI>
        <Literal xml:lang="en">ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#RT-PCR_assay</IRI>
        <Literal xml:lang="en">RT-PCR_assay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Reagent</IRI>
        <Literal xml:lang="en">Reagent</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Reagent</IRI>
        <Literal xml:lang="en">A substance used to produce a chemical reaction so as to detect, measure, or produce other substances.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Refractory_AML_high-risk_MDS_sample</IRI>
        <Literal xml:lang="en">Refractory_AML_high-risk_MDS_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Relapsed_and_refractory_AML_sample</IRI>
        <Literal xml:lang="en">Relapsed_and_refractory_AML_sample</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Renal_cell_cancer</IRI>
        <Literal xml:lang="en">Renal_cell_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ReviewStudy</IRI>
        <Literal xml:lang="en">Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ReviewStudy</IRI>
        <Literal xml:lang="en">ReviewStudy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Review_Study</IRI>
        <Literal xml:lang="en">Review Study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Rhabdomyosarcoma</IRI>
        <Literal xml:lang="en">Rhabdomyosarcoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Role_of_P-GP_in_MDR</IRI>
        <Literal xml:lang="en">Role_of_P-GP_in_MDR</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sarcoma</IRI>
        <Literal xml:lang="en">Sarcoma</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Small_Cell_Lung_Cancer</IRI>
        <Literal xml:lang="en">Small_Cell_Lung_Cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#SouthernBlotting</IRI>
        <Literal xml:lang="en">A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#SouthernBlotting</IRI>
        <Literal xml:lang="en">SouthernBlotting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Southern_Blot_Analysis</IRI>
        <Literal xml:lang="en">Southern_Blot_Analysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Specimen</IRI>
        <Literal xml:lang="en">Specimen</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Specimen</IRI>
        <Literal xml:lang="en">A small sample or part taken to show the nature of the whole, such as a small quantity of urine for urinalysis or a small fragment of tissue for microscopic study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#StatisticalAnalysis</IRI>
        <Literal xml:lang="en">Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#StatisticalAnalysis</IRI>
        <Literal xml:lang="en">StatisticalAnalysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Study</IRI>
        <Literal xml:lang="en">A detailed investigation and analysis of a subject or situation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Study</IRI>
        <Literal xml:lang="en">Study</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#StudyDesign</IRI>
        <Literal xml:lang="en">Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#StudyDesign</IRI>
        <Literal xml:lang="en">StudyDesign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Sulforhodamine-B_cytotoxicity_assay</IRI>
        <Literal xml:lang="en">Sulforhodamine-B_cytotoxicity_assay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Surrogate_Assay</IRI>
        <Literal xml:lang="en">Surrogate_Assay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Catherine_Booth-Genthe</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Gergely_SzakÃ¡cs</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Jill_K._Paterson</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Joseph_A._Ludwig</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Michael_M._Gottesman</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>#Nature_Publishing_Group</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <IRI>https://w3id.org/ScienceOnto/phm#Publisher3</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#Targeting_multidrug_resistance_in_cancer</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">Targeting multidrug resistance in cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Taurocholate</IRI>
        <Literal xml:lang="en">Taurocholate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Taxenes-paclitaxel_docetaxel</IRI>
        <Literal xml:lang="en">Taxenes-paclitaxel_docetaxel</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Teniopside</IRI>
        <Literal xml:lang="en">Teniopside</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Testicular_cancer</IRI>
        <Literal xml:lang="en">Testicular_cancer</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP</IRI>
        <Literal xml:lang="en">The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP</IRI>
        <Literal xml:lang="en">The new transporter was
termed the breast cancer resistance protein (BCRP),
because of its identification in MCF-7 human breast
carcinoma cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#The_physiological_functions_and_structures_of_ABC_transporters</IRI>
        <Literal xml:lang="en">The_physiological_functions_and_structures_of_ABC_transporters</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers</IRI>
        <Literal xml:lang="en">The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers</IRI>
        <Literal xml:lang="en">The physiological functions and structures of ABC transporters, and
development of chemosensitizers are described focusing
on well-known proteins including Pgp, MRP, and BCRP.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Topotecan</IRI>
        <Literal xml:lang="en">Topotecan</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Trastuzumab</IRI>
        <Literal xml:lang="en">Trastuzumab</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#Treatment</IRI>
        <Literal xml:lang="en">A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Treatment</IRI>
        <Literal xml:lang="en">Treatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#VAD</IRI>
        <Literal xml:lang="en">VAD</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Vemurafenib</IRI>
        <Literal xml:lang="en">Vemurafenib</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Verapamil</IRI>
        <Literal xml:lang="en">Verapamil</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Vesicle_transport_experiments</IRI>
        <Literal xml:lang="en">Vesicle_transport_experiments</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Vincristine</IRI>
        <Literal xml:lang="en">Vincristine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Vindesine</IRI>
        <Literal xml:lang="en">Vindesine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#WesternBlotting</IRI>
        <Literal xml:lang="en">A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#WesternBlotting</IRI>
        <Literal xml:lang="en">WesternBlotting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Western_Blot_Analysis</IRI>
        <Literal xml:lang="en">Western_Blot_Analysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Zidovudine</IRI>
        <Literal xml:lang="en">Zidovudine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Zosuquidar</IRI>
        <Literal xml:lang="en">Zosuquidar</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Zosuquidar_AML_experiments</IRI>
        <Literal xml:lang="en">Zosuquidar_AML_experiments</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#addressesStudy</IRI>
        <Literal xml:lang="en">To give attention to or deal with a research or study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#addressesStudy</IRI>
        <Literal xml:lang="en">addressesStudy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#antibody-mediated_cytolysis_experiment</IRI>
        <Literal xml:lang="en">antibody-mediated_cytolysis_experiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#assayTitle</IRI>
        <Literal xml:lang="en">Title of the assay.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#assayTitle</IRI>
        <Literal xml:lang="en">assayTitle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#cDNA</IRI>
        <Literal xml:lang="en">cDNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#ex_vivo</IRI>
        <Literal xml:lang="en">Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ex_vivo</IRI>
        <Literal xml:lang="en">ex_vivo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#examinedBy</IRI>
        <Literal xml:lang="en">To look at or consider a statement carefully and in detail in order to explore and discover.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#examinedBy</IRI>
        <Literal xml:lang="en">examinedBy</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#failureReason</IRI>
        <Literal xml:lang="en">The reasons or causes of a condition or  a fact of not achieving the desired end or ends.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#failureReason</IRI>
        <Literal xml:lang="en">failureReason</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasAssayMethod</IRI>
        <Literal xml:lang="en">Methods used in Assay.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:comment"/>
        <IRI>#hasAssayMethod</IRI>
        <Literal xml:lang="en">Methods used in Assay.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasAssayMethod</IRI>
        <Literal xml:lang="en">hasAssayMethod</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasBlotAnalysis</IRI>
        <Literal xml:lang="en">Experiment uses as a method for the transfer of protein, RNA or DNA molecules.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasBlotAnalysis</IRI>
        <Literal xml:lang="en">useBlotAnalysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasClinicalProblem</IRI>
        <Literal xml:lang="en">Problem or a difficulty, disorder, condition occurs in Clinical Study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasClinicalProblem</IRI>
        <Literal xml:lang="en">hasClinicalProblem</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasDisease</IRI>
        <Literal xml:lang="en">Person who shows a definite pathological process having a characteristic set of signs and symptoms.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasDisease</IRI>
        <Literal xml:lang="en">hasDisease</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasDrugEffects</IRI>
        <Literal xml:lang="en">The ability of a drug or treatment to produce a specific result.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasDrugEffects</IRI>
        <Literal xml:lang="en">hasDrugEffects</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasEligibilityCriteria</IRI>
        <Literal xml:lang="en">Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasEligibilityCriteria</IRI>
        <Literal xml:lang="en">hasEligibilityCriteria</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasEvidence</IRI>
        <Literal xml:lang="en">Information, including verifiable facts and data that support a practice or belief.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasEvidence</IRI>
        <Literal xml:lang="en">hasEvidence</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperiment</IRI>
        <Literal xml:lang="en">Study has a procedure done in order to discover or demonstrate some fact or general truth</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperiment</IRI>
        <Literal xml:lang="en">hasExperiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperimentKit</IRI>
        <Literal xml:lang="en">Identification of the kit/biologicals used in the experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperimentKit</IRI>
        <Literal xml:lang="en">hasExperimentKit</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperimentMaterial</IRI>
        <Literal xml:lang="en">Experiment has materials are culture collections and chemicals used for executing of an experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperimentMaterial</IRI>
        <Literal xml:lang="en">hasExperimentMaterial</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperimentMethod</IRI>
        <Literal xml:lang="en">An experiment has method is a way to solve a scientific task by executing a scientific experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperimentMethod</IRI>
        <Literal xml:lang="en">hasExperimentMethod</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperimentalResult</IRI>
        <Literal xml:lang="en">Identification of Experimental results that are the set of facts and conclusions.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperimentalResult</IRI>
        <Literal xml:lang="en">hasExperimentalResult</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasExperimentalSetting</IRI>
        <Literal xml:lang="en">Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasExperimentalSetting</IRI>
        <Literal xml:lang="en">hasExperimentSetting</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasFindings</IRI>
        <Literal xml:lang="en">A conclusion reached after examination or investigation.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasFindings</IRI>
        <Literal xml:lang="en">hasFindings</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasHypothesis</IRI>
        <Literal xml:lang="en">Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasHypothesis</IRI>
        <Literal xml:lang="en">hasResearchStatement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasInvestigation</IRI>
        <Literal xml:lang="en">Study which acts or processes of examining.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasInvestigation</IRI>
        <Literal xml:lang="en">hasInvestigation</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasLimitations</IRI>
        <Literal xml:lang="en">Conditions or restrictions of research study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasLimitations</IRI>
        <Literal xml:lang="en">hasLimitations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasMutationResult</IRI>
        <Literal xml:lang="en">The result of an alteration or change, as in nature, form, or quality.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasMutationResult</IRI>
        <Literal xml:lang="en">hasMutationResult</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasOverexpressionGene</IRI>
        <Literal xml:lang="en">The Gene that has overexpression which leads to the abundant target protein expression subsequently.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasOverexpressionGene</IRI>
        <Literal xml:lang="en">hasOverexpressionGene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasProblemSolution</IRI>
        <Literal xml:lang="en">Problem has the answer  or the explanation for something.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasProblemSolution</IRI>
        <Literal xml:lang="en">hasProblemSolution</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasProtein</IRI>
        <Literal xml:lang="en">Referencing any of a group of complex organic macromolecules .</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasProtein</IRI>
        <Literal xml:lang="en">hasProtein</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasStudyDesign</IRI>
        <Literal xml:lang="en">Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasStudyDesign</IRI>
        <Literal xml:lang="en">hasStudyDesign</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasSuggestion</IRI>
        <Literal xml:lang="en">An idea is induced in or adopted by another without argument, command, or coercion.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasSuggestion</IRI>
        <Literal xml:lang="en">hasSuggestion</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasTargetingMethod</IRI>
        <Literal xml:lang="en">The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasTargetingMethod</IRI>
        <Literal xml:lang="en">hasTargetingMethod</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasTissueLocalization</IRI>
        <Literal xml:lang="en">A determination of the tissue place of proteins, genes.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasTissueLocalization</IRI>
        <Literal xml:lang="en">hasTissueLocalization</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasTitle</IRI>
        <Literal xml:lang="en">A name that describes something.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasTitle</IRI>
        <Literal xml:lang="en">hasTitle</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#hasTreatment</IRI>
        <Literal xml:lang="en">Defining a period in a clinical study during which subjects receive therapeutic treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#hasTreatment</IRI>
        <Literal xml:lang="en">useTreatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#has_Treatment</IRI>
        <Literal xml:lang="en">Disease that has a therapeutic treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#has_Treatment</IRI>
        <Literal xml:lang="en">hasTreatment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#identify_and_overcome_underlying_mechanisms_of_resistance</IRI>
        <Literal xml:lang="en">identify_and_overcome_underlying_mechanisms_of_resistance</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#identify_and_overcome_underlying_mechanisms_of_resistance</IRI>
        <Literal xml:lang="en">this Review focuses on the mechanisms that enable the survival of cancer
cells during drug treatment and on current research
efforts to identify and overcome underlying mechanisms
of resistance to both standard chemotherapeutic agents
and molecularly targeted therapies.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#in_silico</IRI>
        <Literal xml:lang="en">The mimicking or modeling of biological processes within computer hardware and software.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#in_silico</IRI>
        <Literal xml:lang="en">in_silico</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#in_vitro</IRI>
        <Literal xml:lang="en">In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#in_vitro</IRI>
        <Literal xml:lang="en">in_vitro</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#in_vivo</IRI>
        <Literal xml:lang="en">Biological processes or experiments occurring in the living organism.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#in_vivo</IRI>
        <Literal xml:lang="en">in_vivo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#inhibitors_NB-506_J-107088</IRI>
        <Literal xml:lang="en">inhibitors_NB-506_J-107088</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#investigate</IRI>
        <Literal xml:lang="en">To observe or inquire into in detail; examine systematically.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#investigate</IRI>
        <Literal xml:lang="en">investigate</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#investigatesProblem</IRI>
        <Literal xml:lang="en">To examine an issue, problem, statement of research or study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#investigatesProblem</IRI>
        <Literal xml:lang="en">investigatesProblem</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#isClinicalTrial</IRI>
        <Literal xml:lang="en">Patients are chosen as Clinical Trial for Clinical Study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#isClinicalTrial</IRI>
        <Literal xml:lang="en">isClinicalTrial</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#isClinicalTrial</IRI>
        <Literal xml:lang="en">Patients are chosen as Clinical Trial for Clinical Study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#levels_of_mdr1_mRNA</IRI>
        <Literal xml:lang="en">It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#levels_of_mdr1_mRNA</IRI>
        <Literal xml:lang="en">ResearchStatement</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#mdr1</IRI>
        <Literal xml:lang="en">MDR1</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#mdr1_gene_expression</IRI>
        <Literal xml:lang="en">mdr1_gene_expression</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#multidrug_resistance_to_cancer_cells</IRI>
        <Literal xml:lang="en">multidrug_resistance_to_cancer_cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#name</IRI>
        <Literal xml:lang="en">A word or words by which an entity is designated and distinguished from others.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#obtainedfrom</IRI>
        <Literal xml:lang="en">Get, acquire, or secure something.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#obtainedfrom</IRI>
        <Literal xml:lang="en">obtainedfrom</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#obtainedfromPatient</IRI>
        <Literal xml:lang="en">Get, acquire, or secure specimen from patient.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#obtainedfromPatient</IRI>
        <Literal xml:lang="en">obtainedfromPatient</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#performsExperiment</IRI>
        <Literal xml:lang="en">Clinical Study performs particular Experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#performsExperiment</IRI>
        <Literal xml:lang="en">performsExperiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#refersExperiment</IRI>
        <Literal xml:lang="en">To relate investigation to a particular Experiment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#refersExperiment</IRI>
        <Literal xml:lang="en">refersExperiment</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#resistantTo</IRI>
        <Literal xml:lang="en">Cell definitions resistant to drugs.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#resistantTo</IRI>
        <Literal xml:lang="en">resistantTo</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#testOn</IRI>
        <Literal xml:lang="en">To prove; to try a substance; to determine the chemical nature of a substance on Patient.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#testOn</IRI>
        <Literal xml:lang="en">testOn</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#topoisomerase_I</IRI>
        <Literal xml:lang="en">topoisomerase_I</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#treatmentOutcome</IRI>
        <Literal xml:lang="en">A final product or end result of treatment.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#treatmentOutcome</IRI>
        <Literal xml:lang="en">treatmentOutcome</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useAssay</IRI>
        <Literal xml:lang="en">Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useAssay</IRI>
        <Literal xml:lang="en">useAssay</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useCellLine</IRI>
        <Literal xml:lang="en">Cell Lines  that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useCellLine</IRI>
        <Literal xml:lang="en">useCellLine</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useDrug</IRI>
        <Literal xml:lang="en">Drugs that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useDrug</IRI>
        <Literal xml:lang="en">useDrug</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useGene</IRI>
        <Literal xml:lang="en">Genes that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useGene</IRI>
        <Literal xml:lang="en">useGene</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useProbe</IRI>
        <Literal xml:lang="en">Probes that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useProbe</IRI>
        <Literal xml:lang="en">useProbe</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useReagent</IRI>
        <Literal xml:lang="en">Reagents that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useReagent</IRI>
        <Literal xml:lang="en">useReagent</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useSpecimen</IRI>
        <Literal xml:lang="en">Specimen that are used as material in experimental study.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useSpecimen</IRI>
        <Literal xml:lang="en">useSpecimen</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
        <IRI>#useStatisticalAnalysis</IRI>
        <Literal xml:lang="en">Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#useStatisticalAnalysis</IRI>
        <Literal xml:lang="en">useStatisticalAnalysis</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#10_patients_with_acute_lymphocytic_leukemia</IRI>
        <Literal xml:lang="en">10_patients_with_acute_lymphocytic_leukemia</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#50_patients_with_newly_diagnosed_AML</IRI>
        <Literal xml:lang="en">50_patients_with_newly_diagnosed_AML</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#795-bp_cDNA</IRI>
        <Literal xml:lang="en">795-bp_cDNA</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#99mTc-labeled_compounds_were_exported_via_MRP2â4_and_BCRP</IRI>
        <Literal xml:lang="en">99mTc-labeled_compounds_were_exported_via_MRP2â4_and_BCRP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#99mTc-labeled_compounds_were_exported_via_MRP2â4_and_BCRP</IRI>
        <Literal xml:lang="en">We examinedwhether 99mTc-labeled compounds were
exported via MRP2â4 and BCRP and whether these compounds
had affinity for these transporters including MDR1
and MRP1 in cancer cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells</IRI>
        <Literal>The hypothesis that an ATPdependent xenobiotic transporter may contribute significantly to the multidrug-resistance phenotype of MCF-7yAdrVp cells.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells</IRI>
        <Literal xml:lang="en">ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#BCRP_substrate/inhibitors</IRI>
        <Literal xml:lang="en">BCRP_substrate/inhibitors</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CAV/EP</IRI>
        <Literal xml:lang="en">CAV/EP</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CD34+_Leukemic_Blasts</IRI>
        <Literal xml:lang="en">CD34+_Leukemic_Blasts</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#CD56+</IRI>
        <Literal xml:lang="en">CD56+</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Comparative_CD34+_blast_responses_were_examined</IRI>
        <Literal xml:lang="en">Comparative_CD34+_blast_responses_were_examined</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells</IRI>
        <Literal xml:lang="en">Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="skos:definition"/>
        <IRI>#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells</IRI>
        <Literal xml:lang="en">MCF-7/AdrVp is a multidrug-resistant human
breast cancer subline that displays an ATP-dependent
reduction in the intracellular accumulation of anthracycline
anticancer drugs in the absence of overexpression of known
multidrug resistance transporters such as P glycoprotein or
the multidrug resistance protein.</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#ERBB2âamplified_breast_cancer_cell_lines</IRI>
        <Literal xml:lang="en">ERBB2_amplified_breast_cancer_cell_lines</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#MCF-7/AdrVp_comparison</IRI>
        <Literal xml:lang="en">MCF-7/AdrVp_comparison</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS</IRI>
        <IRI>#Michael_M._Gottesman</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS</IRI>
        <IRI>#Susan_E._Bates</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS</IRI>
        <IRI>#Tito_Fojo</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <IRI>#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS</IRI>
        <IRI>#Macmillan_Magazines_Ltd</IRI>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <IRI>#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS</IRI>
        <Literal datatypeIRI="http://www.w3.org/2000/01/rdf-schema#Literal">MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS</Literal>
    </AnnotationAssertion>
    <AnnotationAssertion>
        <AnnotationProperty abbreviatedIRI="rdfs:label"/>
        <IRI>#PGP/MDR1</IRI>
        <Literal xml:lang="en">PGP/MDR1</Literal>
    </AnnotationAssertion>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:abstract"/>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:accessRights"/>
        <AnnotationProperty abbreviatedIRI="dc:rights"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:alternative"/>
        <AnnotationProperty abbreviatedIRI="dc:title"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:available"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:bibliographicCitation"/>
        <AnnotationProperty abbreviatedIRI="dc:identifier"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:conformsTo"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:contributor"/>
        <AnnotationProperty abbreviatedIRI="dc:contributor"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:coverage"/>
        <AnnotationProperty abbreviatedIRI="dc:coverage"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:created"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <AnnotationProperty abbreviatedIRI="dc:creator"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:date"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:dateAccepted"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:dateCopyrighted"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:dateSubmitted"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:extent"/>
        <AnnotationProperty abbreviatedIRI="dc:format"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:format"/>
        <AnnotationProperty abbreviatedIRI="dc:format"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:hasFormat"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:hasPart"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:hasVersion"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:identifier"/>
        <AnnotationProperty abbreviatedIRI="dc:identifier"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isFormatOf"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isPartOf"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isReferencedBy"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isReplacedBy"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isRequiredBy"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:isVersionOf"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:language"/>
        <AnnotationProperty abbreviatedIRI="dc:language"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:license"/>
        <AnnotationProperty abbreviatedIRI="dc:rights"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:medium"/>
        <AnnotationProperty abbreviatedIRI="dc:format"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <AnnotationProperty abbreviatedIRI="dc:publisher"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:references"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:relation"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:replaces"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:requires"/>
        <AnnotationProperty abbreviatedIRI="dc:relation"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:rights"/>
        <AnnotationProperty abbreviatedIRI="dc:rights"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:source"/>
        <AnnotationProperty abbreviatedIRI="dc:source"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:spatial"/>
        <AnnotationProperty abbreviatedIRI="dc:coverage"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:subject"/>
        <AnnotationProperty abbreviatedIRI="dc:subject"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:tableOfContents"/>
        <AnnotationProperty abbreviatedIRI="dc:description"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:temporal"/>
        <AnnotationProperty abbreviatedIRI="dc:coverage"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <AnnotationProperty abbreviatedIRI="dc:title"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:type"/>
        <AnnotationProperty abbreviatedIRI="dc:type"/>
    </SubAnnotationPropertyOf>
    <SubAnnotationPropertyOf>
        <AnnotationProperty abbreviatedIRI="terms:valid"/>
        <AnnotationProperty abbreviatedIRI="dc:date"/>
    </SubAnnotationPropertyOf>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:accessRights"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:alternative"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:available"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:bibliographicCitation"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:conformsTo"/>
        <AbbreviatedIRI>terms:Standard</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:contributor"/>
        <AbbreviatedIRI>terms:Agent</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:coverage"/>
        <AbbreviatedIRI>terms:LocationPeriodOrJurisdiction</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:created"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <AbbreviatedIRI>terms:Agent</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:creator"/>
        <IRI>http://www.w3.org/2000/10/swap/pim/contact#Person</IRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:date"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:dateAccepted"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:dateCopyrighted"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:dateSubmitted"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <AbbreviatedIRI>xsd:string</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:extent"/>
        <AbbreviatedIRI>terms:SizeOrDuration</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:format"/>
        <AbbreviatedIRI>terms:MediaTypeOrExtent</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:identifier"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:issued"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:language"/>
        <AbbreviatedIRI>terms:LinguisticSystem</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:license"/>
        <AbbreviatedIRI>terms:LicenseDocument</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:medium"/>
        <AbbreviatedIRI>terms:PhysicalMedium</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:modified"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:publisher"/>
        <AbbreviatedIRI>terms:Agent</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:rights"/>
        <AbbreviatedIRI>terms:RightsStatement</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:spatial"/>
        <AbbreviatedIRI>terms:Location</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:temporal"/>
        <AbbreviatedIRI>terms:PeriodOfTime</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:title"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:type"/>
        <AbbreviatedIRI>rdfs:Class</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyRange>
        <AnnotationProperty abbreviatedIRI="terms:valid"/>
        <AbbreviatedIRI>rdfs:Literal</AbbreviatedIRI>
    </AnnotationPropertyRange>
    <AnnotationPropertyDomain>
        <AnnotationProperty abbreviatedIRI="terms:bibliographicCitation"/>
        <AbbreviatedIRI>terms:BibliographicResource</AbbreviatedIRI>
    </AnnotationPropertyDomain>
    <AnnotationPropertyDomain>
        <AnnotationProperty abbreviatedIRI="terms:description"/>
        <IRI>https://w3id.org/ScienceOnto/phm#ResearchStatement</IRI>
    </AnnotationPropertyDomain>
</Ontology>



<!-- Generated by the OWL API (version 4.5.6.2018-09-06T00:27:41Z) https://github.com/owlcs/owlapi -->

